Skip to main content
PMC home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2003 Jan 28;15(3):195–291. doi: 10.1016/0098-2997(94)90042-6

Prions and related neurological diseases

Maurizio Pocchiari 1
PMCID: PMC7133568  PMID: 7968312

The content is available as a PDF (5.1 MB).

References

  1. Abbamondi A.L., Di Trapani G., Pocchiari M., Sbriccoli A., Macchi G. Problèmes de pathologie expèrimentale dans la maladie de Creutzfeldt-Jakob. In: Court L.A., Cathala F., editors. Virus non Conventionnels et Affections du Système Nerveux Central. Masson; Paris: 1983. pp. 309–316. [Google Scholar]
  2. Agrimi U., Di Guardo U., Pocchiari M. Bovine spongiform encephalopathy: an overview. Ann. Ist. Supper. Sanità. 1992;28:497–505. [PubMed] [Google Scholar]
  3. Aguglia U., Farnarier G., Tinuper P., Rey M., Gomez M., Quattrone A. Subacute spongiform encephalopathy with periodic paroxysmal activities: clinical evolution and serial EEG findings in 20 cases. Clin. Electroencephalogr. 1987;18:147–158. [PubMed] [Google Scholar]
  4. Aiken J.M., Marsh R.F. The search for scrapie agent nucleic acid. Microbiol. Rev. 1990;54:242–246. doi: 10.1128/mr.54.3.242-246.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Akai J., Ishihara O., Higuchi S. Creutzfeldt-Jakob disease in Japan: an epidemiological study done in a select prefecture between 1976 and 1986. Neuroepidemiology. 1989;8:32–37. doi: 10.1159/000110162. [DOI] [PubMed] [Google Scholar]
  6. Alemà G., Bignami A. Polioencefalopatia degenerativa subacuta del presenio con stupore acinetico e rigidità decorticata con mioclonie (varietà “mioclonica” della malattia di Jakob-Creutzfeldt) Riv. Sper. Freniat. 1959;83(Suppl.4):1485–1623. [PubMed] [Google Scholar]
  7. Alper T., Haig D.A., Clarke M.C. The exceptionally small size of the scrapie agent. Biochem. Biophys. Res. Commun. 1966;22:278–284. doi: 10.1016/0006-291x(66)90478-5. [DOI] [PubMed] [Google Scholar]
  8. Alper T., Haig D.A., Clarke M.C. The scrapie agent: evidence against its dependence for replication on intrinsic nucleic acid. J. Gen. Virol. 1978;41:503–516. doi: 10.1099/0022-1317-41-3-503. [DOI] [PubMed] [Google Scholar]
  9. Alperovitch A., Brown P., Weber T., Pocchiari M., Hofman A., Will R. Incidence of Creutzfeldt-Jakob disease in Europe in 1993. Lancet. 1994;343:918. doi: 10.1016/s0140-6736(94)90037-x. [DOI] [PubMed] [Google Scholar]
  10. Alter M., Hoenig E., Pratzon G. Creutzfeldt-Jakob disease: possible association with eating brains. N. Engl. J. Med. 1977;296:820–821. doi: 10.1056/nejm197704072961420. [DOI] [PubMed] [Google Scholar]
  11. Amyx H., Salazar A.M., Gajdusek D.C., Gibbs C.J., Jr Chemotherapeutic trials in experimental slow virus disease. Neurology. 1984;34(Suppl.1):149. [Google Scholar]
  12. Baker H.F., Ridley R.M., Crow T.J. Experimental transmission of an autosomal dominant spongiform encephalopathy: does the infectious agent originate in the human genome? Br. Med. J. 1985;291:299–302. doi: 10.1136/bmj.291.6491.299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Baker H.F., Poulter M., Crow T.J., Frith C.D., Lofthouse R., Ridley R.M. Amino acid polymorphism in human prion protein and age death in inherited prion disease. Lancet. 1991;337:1289. doi: 10.1016/0140-6736(91)92953-y. [DOI] [PubMed] [Google Scholar]
  14. Baker H.F., Ridley R.M., Wells G.A.H. Experimental transmission of BSE and scrapie to the common marmoset. Vet. Rec. 1993;132:403–406. doi: 10.1136/vr.132.16.403. [DOI] [PubMed] [Google Scholar]
  15. Baldwin M.A., Stahl N., Reinders L.G., Gibson B.W., Prusiner S.B., Burlingame A.L. Permethylation and tandem mass spectrometry of oligosaccharides having free hexosamine: analysis of the glycoinositol phospholipid anchor glycan from the scrapie prion protein. Anal. Biochem. 1990;191:174–182. doi: 10.1016/0003-2697(90)90405-x. [DOI] [PubMed] [Google Scholar]
  16. Barbanti P., Fabrini G., Salvatore M., Buzzi M.G., Di Piero V., Petraroli R., Sbriccoli A., Pocchiari M., Macchi G., Lenzi G.L. Rapidly progressive Gerstmann-Sträussler-Scheinker syndrome (GSS) with codon 102 mutation of prion protein gene (PRNP) in a large Italian kindred. 4th Meeting of the European Neurological Society; Barcelona 25–29 June; 1994. [Google Scholar]
  17. Barker D., Schafer M., White R. Restriction sites containing CpG show a higher frequency of polymorphism in human DNA. Cell. 1984;36:131–138. doi: 10.1016/0092-8674(84)90081-3. [DOI] [PubMed] [Google Scholar]
  18. Barlow R.M., Middleton D.J. Dietary transmission of bovine spongiform encephalopathy to mice. Vet. Rec. 1990;126:111–112. [PubMed] [Google Scholar]
  19. Basler K., Oesch B., Scott M., Westaway D., Walchli M., Groth D.F., McKinley M.P., Prusiner S.B., Weissmann C. Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene. Cell. 1986;46:417–428. doi: 10.1016/0092-8674(86)90662-8. [DOI] [PubMed] [Google Scholar]
  20. Bates P., Young J.A.T., Varmus H.E. A receptor for subgroup A Rous sarcoma virus is related to the low density lipoprotein receptor. Cell. 1993;74:1043–1051. doi: 10.1016/0092-8674(93)90726-7. [DOI] [PubMed] [Google Scholar]
  21. Bell J.E., Ironside J.W. Neuropathology of spongiform encephalopathies in humans. Br. Med. Bull. 1993;49:738–777. doi: 10.1093/oxfordjournals.bmb.a072645. [DOI] [PubMed] [Google Scholar]
  22. Bellinger Kawahara C.G., Cleaver J.E., Diener T.O., Prusiner S.B. Purified scrapie prions resist inactivation by UV irradiation. J. Virol. 1987;61:159–166. doi: 10.1128/jvi.61.1.159-166.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Bellinger Kawahara C.G., Diener T.O., McKinley M.P., Groth D.F., Smith D.R., Prusiner S.B. Purified scrapie prions resist inactivation by procedures that hydrolyze, modify, or shear nucleic acids. Virology. 1987;160:271–274. doi: 10.1016/0042-6822(87)90072-9. [DOI] [PubMed] [Google Scholar]
  24. Bendheim P.E., Barry R.A., DeArmond S.J., Stites D.P., Prusiner S.B. Antibodies to a scrapie prion protein. Nature. 1984;310:418–421. doi: 10.1038/310418a0. [DOI] [PubMed] [Google Scholar]
  25. Bendheim P.E., Potempska A., Kascsak R.J., Bolton D.C. Purification and partial characterization of the normal cellular homologue of the scrapie agent protein. J. Infect. Dis. 1988;158:1198–1208. doi: 10.1093/infdis/158.6.1198. [DOI] [PubMed] [Google Scholar]
  26. Berg L.J. Vol. 91. 1994. Insights into the role of the immune system in prion diseases; pp. 429–432. (Proc. Natl. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Berger J.R., Noble J.D. Creutzfeldt-Jakob disease in a physician: A review of the disorder in health care workers. Neurology. 1993;43:205–206. doi: 10.1212/wnl.43.1_part_1.205. [DOI] [PubMed] [Google Scholar]
  28. Bernoulli C., Siegfried J., Baumgartner G., Regli F., Rabinowicz T., Gajdusek D.C., Gibbs C.J., Jr Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery. Lancet. 1977;1:478–479. doi: 10.1016/s0140-6736(77)91958-4. [DOI] [PubMed] [Google Scholar]
  29. Bertoni J.M., Brown P., Goldfarb L.G., Rubenstein R., Gajdusek D.C. Familial Creutzfeldt Jakob disease (codon 200 mutation) with supranuclear palsy. JAMA. 1992;268:2413–2415. [PubMed] [Google Scholar]
  30. Bessen R.A., Marsh R.F. Identification of two biologically distinct strains of trasmissible mink encephalopathy in hamster. J. Gen. Virol. 1992;73:329–334. doi: 10.1099/0022-1317-73-2-329. [DOI] [PubMed] [Google Scholar]
  31. Bessen R.A., Marsh R.F. Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent. J. Virol. 1992;66:2096–2101. doi: 10.1128/jvi.66.4.2096-2101.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Blisard K.S., Davis L.E., Harrington M.G., Lovell J.K., Kornfeld M., Berger M.L. Pre-mortem diagnosis of Creutzfeldt-Jakob disease by detection of abnormal cerebrospinal fluid proteins. J. Neurol. Sci. 1990;99:75–81. doi: 10.1016/0022-510x(90)90201-w. [DOI] [PubMed] [Google Scholar]
  33. Bobowick A.R., Brody J.A., Matthews M.R., Roos R., Gajdusek D.C. Creutzfeldt-Jakob disease: a case-control study. Am. J. Epidem. 1973;98:381–394. doi: 10.1093/oxfordjournals.aje.a121567. [DOI] [PubMed] [Google Scholar]
  34. Bockman J.M., Kingsbury D.T., McKinley M.P., Bendheim P.E., Prusiner S.B. Creutzfeldt-Jakob disease prion proteins in human brains. N. Engl. J. Med. 1985;312:73–78. doi: 10.1056/NEJM198501103120202. [DOI] [PubMed] [Google Scholar]
  35. Bockman J.M., Prusiner S.B., Tateishi J., Kingsbury D.T. Immunoblotting of Creutzfeldt-Jakob disease prion proteins: host species-specific epitopes. Ann. Neurol. 1987;21:589–595. doi: 10.1002/ana.410210611. [DOI] [PubMed] [Google Scholar]
  36. Bode L., Pocchiari M., Gelderblom H., Diringer H. Characterization of antisera against scrapie-associated fibrils (SAF) from affected hamster and cross-reactivity with SAF from scrapie-affected mice and from patients with Creutzfeldt-Jakob disease. J. Gen. Virol. 1985;66:2471–2478. doi: 10.1099/0022-1317-66-11-2471. [DOI] [PubMed] [Google Scholar]
  37. Bolton D.C., McKinley M.P., Prusiner S.B. Identification of a protein that purifies with the scrapie prion. Science. 1982;218:1309–1311. doi: 10.1126/science.6815801. [DOI] [PubMed] [Google Scholar]
  38. Bolton D.C., Meyer R.K., Prusiner S.B. Scrapie PrP 27–30 is a sialoglycoprotein. J. Virol. 1985;53:596–606. doi: 10.1128/jvi.53.2.596-606.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Bolton D.C., Bendheim P.E., Marmorstein A.D., Potempska A. Isolation and structural studies of the intact scrapie agent protein. Arch. Biochem. Biophys. 1987;258:579–590. doi: 10.1016/0003-9861(87)90380-8. [DOI] [PubMed] [Google Scholar]
  40. Bolton D.C., Rudelli R.D., Currie J.R., Bendheim P.E. Copurification of Sp33–37 and scrapie agent from hamster brain prior to detectable histopathology and clinical disease. J. Gen. Virol. 1991;72:2905–2913. doi: 10.1099/0022-1317-72-12-2905. [DOI] [PubMed] [Google Scholar]
  41. Borchelt D.R., Scott M., Taraboulos A., Stahl N., Prusiner S.B. Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells. J. Cell Biol. 1990;110:743–752. doi: 10.1083/jcb.110.3.743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Borchelt D.R., Taraboulos A., Prusiner S.B. Evidence for synthesis of scrapie prion proteins in the endocytic pathway. J. Biol. Chem. 1992;267:16188–16199. [PubMed] [Google Scholar]
  43. Bosque P.J., Vnencak Jones C.L., Johnson M.D., Whitlock J.A., Mclean M.J. A PrP gene codon-178 base substitution and a 24-bp interstitial deletion in familial Creutzfeldt Jakob disease. Neurology. 1992;42:1864–1870. doi: 10.1212/wnl.42.10.1864. [DOI] [PubMed] [Google Scholar]
  44. Bots G.T., Man J.C., Verjaal A. Virus-like particles in brain tissue from two patients with Creutzfeldt-Jakob disease. Acta Neuropathol. (Berl.) 1971;18:267–270. doi: 10.1007/BF00685073. [DOI] [PubMed] [Google Scholar]
  45. Braham J. Jakob-Creutzfeldt disease: treatment by amantadine. Br. Med. J. 1971;4:212–213. doi: 10.1136/bmj.4.5781.212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Brown H.R., Goller N.L., Rudelli R.D., Merz G.S., Wolfe G.C., Wisniewski H.M., Robakis N.K. The mRNA encoding the scrapie agent protein is present in a variety of non-neuronal cells. Acta Neuropathol. (Berl.) 1990;80:1–6. doi: 10.1007/BF00294214. [DOI] [PubMed] [Google Scholar]
  47. Brown P. Human growth hormone therapy and Creutzfeldt-Jakob disease: a drama in three acts. Pediatrics. 1988;81:85–92. [PubMed] [Google Scholar]
  48. Brown P. Chemotherapy of unconventional virus infections of the central nervous system. In: Field H.J., editor. Vol. 2. CRC Press; Boca Raton: 1988. pp. 13–28. (Antiviral Agents: the Development and Assessment of Antiviral Chemotherapy). [Google Scholar]
  49. Brown P. Vol. 135. 1988. The clinical neurology and epidemiology of Creutzfeldt-Jakob disease, with special reference to iatrogenic cases; pp. 3–23. (Ciba Found. Symp.). [DOI] [PubMed] [Google Scholar]
  50. Brown P. A therapeutic panorama of the spongiform encephalopathies. Antiv. Chem. Chemother. 1990;1:75–83. [Google Scholar]
  51. Brown P. The phantasmagoric immunology of transmissible spongiform encephalopathy. In: Waksman B.H., editor. Immunologic Mechanisms in Neurologic and Psychiatric Disease. Raven Press; New York: 1990. pp. 305–313. [Google Scholar]
  52. Brown P. EEG findings in Creutzfeldt-Jakob disease. JAMA. 1993;269:3168. doi: 10.1001/jama.269.24.3168. [DOI] [PubMed] [Google Scholar]
  53. Brown P. Infectious cerebral amyloidosys: clinical spectrum, risks and remedies. Dev. Biol. Stand. 1993;80:91–101. [PubMed] [Google Scholar]
  54. Brown P., Cathala F., Gajdusek D.C. Creutzfeldt-Jakob disease in France: III. Epidemiological study of 170 patients dying during the decade 1968–1977. Ann. Neurol. 1979;6:438–446. doi: 10.1002/ana.410060511. [DOI] [PubMed] [Google Scholar]
  55. Brown P., Gibbs C.J., Jr, Amyx H.L., Kingsbury D.T., Rohwer R.G., Sulima M.P., Gajdusek D.C. Chemical disinfection of Creutzfeldt-Jakob disease virus. N. Engl. J. Med. 1982;306:1279–1282. doi: 10.1056/NEJM198205273062107. [DOI] [PubMed] [Google Scholar]
  56. Brown P., Rodgers Johnson P., Cathala F., Gibbs C.J., Jr, Gajdusek D.C. Creutzfeldt-Jakob disease of long duration: clinicopathological characteristics, transmissibility, and differential diagnosis. Ann. Neurol. 1984;16:295–304. doi: 10.1002/ana.410160305. [DOI] [PubMed] [Google Scholar]
  57. Brown P., Gajdusek D.C., Gibbs C.J., Jr, Asher D.M. Potential epidemic of Creutzfeldt-Jakob disease from human growth hormone therapy. N. Engl. J. Med. 1985;313:728–731. doi: 10.1056/NEJM198509193131205. [DOI] [PubMed] [Google Scholar]
  58. Brown P., Cathala F., Castaigne P., Gajdusek D.C. Creutzfeldt-Jakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases. Ann. Neurol. 1986;20:597–602. doi: 10.1002/ana.410200507. [DOI] [PubMed] [Google Scholar]
  59. Brown P., Coker Vann M., Pomeroy K.L., Franko M., Asher D.M., Gibbs C.J., Jr, Gajdusek D.C. Diagnosis of Creutzfeldt-Jakob disease by Western blot identification of marker protein in human brain tissue. N. Engl. J. Med. 1986;314:547–551. doi: 10.1056/NEJM198602273140904. [DOI] [PubMed] [Google Scholar]
  60. Brown P., Rohwer R.G., Gajdusek D.C. Newer data on the inactivation of scrapie virus or Creutzfeldt-Jakob disease virus in brain tissue. J. Infect. Dis. 1986;153:1145–1148. doi: 10.1093/infdis/153.6.1145. [DOI] [PubMed] [Google Scholar]
  61. Brown P., Cathala F., Raubertas R.F., Gajdusek D.C., Castaigne P. The epidemiology of Creutzfeldt-Jakob disease: conclusion of a 15-year investigation in France and review of the world literature. Neurology. 1987;37:895–904. doi: 10.1212/wnl.37.6.895. [DOI] [PubMed] [Google Scholar]
  62. Brown P., Liberski P.P., Wolff A., Gajdusek D.C. Resistance of scrapie infectivity to steam autoclaving after formaldehyde fixation and limited survival after ashing at 360 degrees C: practical and theoretical implications. J. Infect. Dis. 1990;161:467–472. doi: 10.1093/infdis/161.3.467. [DOI] [PubMed] [Google Scholar]
  63. Brown P., Goldfarb L.G., Brown W.T., Goldgaber D., Rubenstein R., Kascsak R.J., Guiroy D.C., Piccardo P., Boellaard J.W., Gajdusek D.C. Clinical and molecular genetic study of a large German Kindred with Gerstmann-Sträussler-Sheinker Syndrome. Neurology. 1991;41:375–379. doi: 10.1212/wnl.41.3.375. [DOI] [PubMed] [Google Scholar]
  64. Brown P., Galvev S., Goldfarb L.G., Nieto A., Carter L., Gibbs C.J., Jr, Gajdusek D.C. Familial Creutzfeldt-Jakob Disease in Chile is associated with the codon 200 mutation of the PRNP amyloid precursor gene on chromosome 20. J. Neurol. Sci. 1992;112:65–67. doi: 10.1016/0022-510x(92)90133-6. [DOI] [PubMed] [Google Scholar]
  65. Brown P., Goldfarb L.G., Kovanen J., Haltia M., Cathala F., Sulima M., Gibbs C.J., Jr, Gajdusek D.C. Phenotipic characteristic of familial Creutzfeldt-Jakob disease associated with the codon 178 ASN PRNP mutation. Ann. Neurol. 1992;31:282–285. doi: 10.1002/ana.410310309. [DOI] [PubMed] [Google Scholar]
  66. Brown P., Kaur P., Sulima M.P., Goldfarb L.G., Gibbs C.J., Jr, Gajdusek D.C. Real and imagined clinicopathological limits of ‘prion dementia’. Lancet. 1993;341:127–129. doi: 10.1016/0140-6736(93)90001-w. [DOI] [PubMed] [Google Scholar]
  67. Brown P., Cervenáková L., Goldfarb L.G., McCombie W.R., Rubenstein R., Will R.G., Pocciari M., Martinez-Lage J.F., Scalici C., Masullo C., Graupera G., Ligan J., Gajdusek D.C. Iatrogenic Creutzfeldt-Jakob disease: An example of the interplay between ancient genes and modern medicine. Neurology. 1994;44:291–293. doi: 10.1212/wnl.44.2.291. [DOI] [PubMed] [Google Scholar]
  68. Brown P., Gibbs C.J., Jr, Rodgers Johnson P., Asher D.M., Sulima M.P., Bacote A., Goldfarb L.G., Gajdusek D.C. Human spongiform encephalopathy: the NIH series of 300 cases of experimentally transmitted disease. Ann. Neurol. 1994;35:513–529. doi: 10.1002/ana.410350504. [DOI] [PubMed] [Google Scholar]
  69. Bruce M.E. Scrapie strain variation and mutation. Br. Med. Bull. 1993;49:822–838. doi: 10.1093/oxfordjournals.bmb.a072649. [DOI] [PubMed] [Google Scholar]
  70. Bruce M.E., Fraser H. Focal and asymmetrical vacuolar lesions in the brains of mice infected with certain strains of scrapie. Acta Neuropathol. (Berl.) 1982;58:133–140. doi: 10.1007/BF00691654. [DOI] [PubMed] [Google Scholar]
  71. Bruce M.E., McConnell I., Fraser H., Dickinson A.G. The disease charateristics of different strains of scrapie in Sinc congenic mouse lines: implications for the nature of the agent and host control of pathogenesis. J. Gen. Virol. 1991;72:595–603. doi: 10.1099/0022-1317-72-3-595. [DOI] [PubMed] [Google Scholar]
  72. Büeler H., Fischer M., Lang Y., Bluethmann H., Lipp H.P., DeArmond S.J., Prusiner S.B., Aguet M., Weissmann C. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature. 1992;356:577–582. doi: 10.1038/356577a0. [DOI] [PubMed] [Google Scholar]
  73. Büeler H., Aguzzi A., Sailer A., Greiner R.-A., Autenried P., Aguet M., Weissmann C. Mice devoid of PrP are resistant to scrapie. Cell. 1993;73:1339–1347. doi: 10.1016/0092-8674(93)90360-3. [DOI] [PubMed] [Google Scholar]
  74. Campbell I.L., Abraham C.R., Masliah E., Kemper P., Inglis J.D., Oldstone M.B.A., Mucke L. Vol. 90. 1993. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6; pp. 10061–10065. (Proc. Natl. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Carlson G.A., Kingsbury D.T., Goodman P.A., Coleman S., Marshall S.T., DeArmond S.J., Westaway D., Prusiner S.B. Linkage of prion protein and scrapie incubation time genes. Cell. 1986;46:503–511. doi: 10.1016/0092-8674(86)90875-5. [DOI] [PubMed] [Google Scholar]
  76. Carp R.I. Scrapie. Unconventional infectious agent. In: Specter S., editor. Neuropathogenic Viruses and Immunity. Plenum Press; New York: 1992. pp. 111–136. [Google Scholar]
  77. Carp R.I., Kascsak R.J., Rubenstein R., Merz P.A. The puzzle of PrPsc and infectivity — do the pieces fit? Trends Neurosci. 1994;14:148–149. doi: 10.1016/0166-2236(94)90090-6. [DOI] [PubMed] [Google Scholar]
  78. Casaccia P., Ladogana A., Xi Y.G., Pocchiari M. Levels of infectivity in the blood throughout the incubation period of hamsters peripherally injected with scrapie. Arch. Virol. 1989;108:145–149. doi: 10.1007/BF01313752. [DOI] [PubMed] [Google Scholar]
  79. Casaccia P., Ladogana A., Masullo C., Macchi G., Pocchiari M. Possible implications of the cellular component of the immune system in the pathogenesis of unconventional slow virus infections. In: Marrosu M.G., Cianchetti C., Tavolato B., editors. Trends in Neuroimmunology. Plenum Press; New York: 1990. pp. 135–149. [Google Scholar]
  80. Casaccia P., Ladogana A., Xi Y.G., Ingrosso L., Pocchiari M., Silvestrini M.C., Cittadini A. Measurement of the concentration of amphotericin B in brain tissue of scrapie-infected hamsters with a simple and sensitive method. Antimicrob. Agents Chemother. 1991;35:1486–1488. doi: 10.1128/aac.35.7.1486. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Caughey B., Race R.E. Potent inibition of scrapie associated PrP accumulation by Congo red. J. Neurochem. 1992;59:768–771. doi: 10.1111/j.1471-4159.1992.tb09437.x. [DOI] [PubMed] [Google Scholar]
  82. Caughey B., Raymond G.J. The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive. J. Biol. Chem. 1991;266:18217–18223. [PubMed] [Google Scholar]
  83. Caughey B., Raymond G.J. Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells. J. Virol. 1993;67:643–650. doi: 10.1128/jvi.67.2.643-650.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Caughey B., Race R.E., Chesebro B. Detection of prion protein mRNA in normal and scrapie-infected tissues and cell lines. J. Gen. Virol. 1988;69:711–716. doi: 10.1099/0022-1317-69-3-711. [DOI] [PubMed] [Google Scholar]
  85. Caughey B., Race R.E., Ernst D., Buchmeier M.J., Chesebro B. Prion protein biosynthesis in scrapie-infected and uninfected neuroblastoma cells. J. Virol. 1989;63:175–181. doi: 10.1128/jvi.63.1.175-181.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Caughey B., Neary K., Buller R., Ernst D., Perry L.L., Chesebro B., Race R.E., Pattison I. Normal and scrapie-associated forms of prion protein differ in their sensitivities to phospholipase and proteases in intact neuroblastoma cells. J. Virol. 1990;126:68–101. doi: 10.1128/jvi.64.3.1093-1101.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Caughey B., Raymond G.J., Ernst D., Race R.E. N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state. J. Virol. 1991;65:6597–6603. doi: 10.1128/jvi.65.12.6597-6603.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Caughey B., Dong A., Bhat K.S., Ernst D., Hayes S.F., Caughey W.S. Secondary structure analysis of the scrapie-associated protein PrP 27–30 in water by infrared spectroscopy. Biochemistry. 1991;30:7672–7680. doi: 10.1021/bi00245a003. [DOI] [PubMed] [Google Scholar]
  89. Caughey B., Ernst D., Race R.E. Congo red inhibition of scrapie agent replication. J. Virol. 1993;67:6270–6272. doi: 10.1128/jvi.67.10.6270-6272.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Ceroni M., Piccardo P., Safar J., Gajdusek D.C., Gibbs C.J., Jr Scrapie infectivity and prion protein are distributed in the same pH range in agarose isoelectric focusing. Neurology. 1990;40:508–513. doi: 10.1212/wnl.40.3_part_1.508. [DOI] [PubMed] [Google Scholar]
  91. Chandler R.L. Experimental scrapie in mouse. Res. Vet. Sci. 1963;4:276–285. [Google Scholar]
  92. Chapman J., Brown P., Goldfarb L.G., Arlazoroff A., Gajdusek D.C., Korczyn A.D. Clinical heterogeneity and unusual presentations of Creutzfeldt-Jakob disease in Jewish patients with the PRNP codon 200 mutation. J. Neurol. Neurosurg. Psychiatry. 1993;56:1109–1112. doi: 10.1136/jnnp.56.10.1109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Chelle P.L. Un cas de tremblante chez la chèvre. Bull. Acad. Vét. de France. 1942;15:294–295. [Google Scholar]
  94. Chesebro B. Spongiform encephalopathies: the transmissible agents. In: Fields B.N., Knipe D.M., editors. Virology. Raven Press; New York: 1990. pp. 2325–2336. [Google Scholar]
  95. Chesebro B., Race R.E., Wehrly K., Nishio J., Bloom M., Lechner D., Bergstrom S., Robbins K., Mayer L., Keith J.M., Garon C., Haase A. Identification of scrapie prion protein-specific mRNA in scrapie-infected and uninfected brain. Nature. 1985;315:331–333. doi: 10.1038/315331a0. [DOI] [PubMed] [Google Scholar]
  96. Chesebro B., Wehrly K., Caughey B., Nishio J., Ernst D., Race R. Foreign PrP expression and scrapie infection in tissue culture cell lines. Dev. Biol. Stand. 1993;80:131–140. [PubMed] [Google Scholar]
  97. Chiofalo N., Fuentes A., Galvev S. Serial EEG findings in 27 cases of Creutzfeldt-Jakob disease. Arch. Neurol. 1980;37:143–145. doi: 10.1001/archneur.1980.00500520041005. [DOI] [PubMed] [Google Scholar]
  98. Cho H.J., Greig A.S. Isolation of 14-nm virus-like particles from mouse brain infected with scrapie agent. Nature. 1975;257:685–686. doi: 10.1038/257685a0. [DOI] [PubMed] [Google Scholar]
  99. Clarke M.C., Kimberlin R.H. Pathogenesis of mouse scrapie: distribution of agent in the pulp and stroma of infected spleens. Vet Microbiol. 1984;9:215–225. doi: 10.1016/0378-1135(84)90039-7. [DOI] [PubMed] [Google Scholar]
  100. Cochius J.I., Burns R.J., Blumbergs P.C., Mack K., Alderman C.P. Creutzfeldt-Jakob disease in a recipient of human pituitary-derived gonadotrophin. Aust. N.Z. J. Med. 1990;20:592–593. doi: 10.1111/j.1445-5994.1990.tb01322.x. [DOI] [PubMed] [Google Scholar]
  101. Cochran K.W. Vol. 30. 1971. Failure of amantadine HCl to alter scrapie in mice; p. 679. (Fed. Proc.). [Google Scholar]
  102. Collinge J., Palmer M.S., Dryden A.J. Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease. Lancet. 1991;337:1441–1442. doi: 10.1016/0140-6736(91)93128-v. [DOI] [PubMed] [Google Scholar]
  103. Collinge J., Brown J., Hardy J., Mullan M.J., Rossor M.N., Baker H., Crow T.J., Lofthouse R., Poulter M., Ridley R.M., Owen F., Bennet C., Dunn G., Harding A.E., Quinn N., Doshi B., Roberts G.W., Honavar M., Janota I., Lantos P.L. Inherited prion disease with 144 base pair gene insertion. 2. Clinical and pathological features. Brain. 1992;115:687–710. doi: 10.1093/brain/115.3.687. [DOI] [PubMed] [Google Scholar]
  104. Creutzfeldt H.G. Über eine eigenartige herdförmige Erkrangung des Zentral-nervensystems. Z. ges. Neurol. Psychiat. 1920;57:1–18. [Google Scholar]
  105. Creutzfeldt H.G. In: Histologische und Histopathologische Arbeiten über die Grosshirnrinde. Nissl F., Alzheimer A., editors. vol. 6. Gustav Fisher; Jena: 1921. pp. 1–48. (Über eine eigenartige herdförmige Erkrankung des Zentral-nervensystems). [Google Scholar]
  106. Cuillé J., Chelle P.L. La maladie dite tremblant du mouton est-elle inoculable? C. R. Acad. Sci. (Paris) 1936;203:1552–1554. [Google Scholar]
  107. Cutler N.R., Brown P.W., Narayan T., Parisi J.E., Janotta F., Baron H. Creutzfeldt-Jakob disease: a case of 16 years' duration. Ann. Neurol. 1984;15:107–110. doi: 10.1002/ana.410150121. [DOI] [PubMed] [Google Scholar]
  108. Czub M., Braig H.R., Diringer H. Pathogenesis of scrapie: study of the temporal development of clinical symptoms, of infectivity titres and scrapie-associated fibrils in brains of hamsters infected intraperitoneally. J. Gen. Virol. 1986;67:2005–2009. doi: 10.1099/0022-1317-67-9-2005. [DOI] [PubMed] [Google Scholar]
  109. Czub M., Braig H.R., Diringer H. Replication of the scrapie agent in hamsters infected intracerebrally confirms the pathogenesis of an amyloid-inducing virosis. J. Gen. Virol. 1988;69:1753–1756. doi: 10.1099/0022-1317-69-7-1753. [DOI] [PubMed] [Google Scholar]
  110. Dalgleish A.G., Beverley P.C.L., Clapham P.R., Crawford D.H., Greaves M.F., Weiss R.A. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature. 1984;312:763–767. doi: 10.1038/312763a0. [DOI] [PubMed] [Google Scholar]
  111. Davanipour Z., Alter M., Sobel E., Asher D.M., Gajdusek D.C. A case-control study of Creutzfeldt-Jakob disease. Dietary risk factors. Am. J. Epidem. 1985;122:443–451. doi: 10.1093/oxfordjournals.aje.a114125. [DOI] [PubMed] [Google Scholar]
  112. Davies P.T.G., Jahfar S., Ferguson I.T., Windi O. Creutzfeldt-Jakob disease in individual occupationally exposed to BSE. Lancet. 1993;342:680. doi: 10.1016/0140-6736(93)91787-m. [DOI] [PubMed] [Google Scholar]
  113. Dawson M., Wells G.A.H., Parker B.N.J., Scott A.C. Primary parenteral transmission of bovine spongiform encephalopathy to the pig. Vet. Rec. 1990;127:338. [PubMed] [Google Scholar]
  114. Dealler S.F., Lacey R.W. Trasmissible spongiform encephalopathies. The threat of BSE to man. Food Microbiol. 1990;7:253–279. [Google Scholar]
  115. DeArmond S.J., Prusiner S.B. The neurochemistry of prion diseases. J. Neurochem. 1993;61:1589–1601. doi: 10.1111/j.1471-4159.1993.tb09792.x. [DOI] [PubMed] [Google Scholar]
  116. Delmas B., Gelfi J., L'Haridon R., Vogel L.K., Sjöström H., Norèn O., Laude H. Aminopeptidase N is a major receptor for the entero-pathogenic coronavirus TGEV. Nature. 1992;357:417–420. doi: 10.1038/357417a0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Demaimay R., Lasmézas C., Deslys J.P., Seman M., Dormont D. IX Int. Congr. Virol. 1993. Pharmacological studies of amphotericin B derivative, MS-8209, in mouse scrapie; p. 94. abstract n. W59-6. [Google Scholar]
  118. Deslys J.P., Marcé D., Dormont D. Similar genetic susceptibility in iatrogenic and sporadic Creutzfeldt-Jakob disease. J. Gen. Virol. 1994;75:23–27. doi: 10.1099/0022-1317-75-1-23. [DOI] [PubMed] [Google Scholar]
  119. Di Martino A., Safar J., Ceroni M., Gibbs C.J., Jr Purification of non-infectious ganglioside preparations from scrapie-infected brain tissue. Arch. Virol. 1992;124:111–121. doi: 10.1007/BF01314629. [DOI] [PubMed] [Google Scholar]
  120. Di Martino A., Safar J., Ceroni M., Gibbs C.J., Jr Inactivation of the scrapie agent in a scaled-down procedure for the purification of gangliosides from brain tissue. Dev. Biol. Stand. 1993;80:187–194. [PubMed] [Google Scholar]
  121. Dickinson A.G. Scrapie in sheep and goats. Front. Biol. 1976;44:209–241. [PubMed] [Google Scholar]
  122. Dickinson A.G., Fraser H. Scrapie: effect of Dh gene on incubation period of extraneurally injected agent. Heredity Edinburgh. 1972;29:91–93. doi: 10.1038/hdy.1972.67. [DOI] [PubMed] [Google Scholar]
  123. Dickinson A.G., Meikle V.M. Host-genotype and agent effects in scrapie incubation: change in allelic interaction with different strains of agent. Mol. Gen. Genet. 1971;112:73–79. doi: 10.1007/BF00266934. [DOI] [PubMed] [Google Scholar]
  124. Dickinson A.G., Outram G.W. The scrapie replication-site hypothesis and its implications for pathogenesis. In: Prusiner S.B., Hadlow W.J., editors. Vol.2. Academic Press; New York: 1979. pp. 13–31. (Slow Transmissible Diseases of the Nervous System). [Google Scholar]
  125. Dickinson A.G., Outram G.W. Operational limitations in the characterization of the infective units of scrapie. In: Court L.A., editor. Virus non Conventionnels et Affections du Système Nerveux Central. Masson; Paris: 1983. pp. 3–16. [Google Scholar]
  126. Dickinson A.G., Outram G.W. Vol. 135. 1988. Genetic aspects of unconventional virus infections: the basis of the virino hypothesis; pp. 63–83. (Ciba Found. Symp.). [DOI] [PubMed] [Google Scholar]
  127. Dickinson A.G., Meikle V.M., Fraser H. Identification of a gene which controls the incubation period of some strains of scrapie agent in mice. J. Comp. Pathol. 1968;78:293–299. doi: 10.1016/0021-9975(68)90005-4. [DOI] [PubMed] [Google Scholar]
  128. Dickinson A.G., Stamp J.T., Renwick C.C., Rennie J.C. Some factors controlling the incidence of scrapie in Cheviot sheep injected with a Cheviot-passaged scrapie agent. J. Comp. Pathol. 1968;78:313–321. doi: 10.1016/0021-9975(68)90007-8. [DOI] [PubMed] [Google Scholar]
  129. Dickinson A.G., Fraser H., Meikle V.M., Outram G.W. Competition between different scrapie agents in mice. Nature New Biol.l. 1972;237:244–245. doi: 10.1038/newbio237244a0. [DOI] [PubMed] [Google Scholar]
  130. Dickinson A.G., Stamp J.T., Renwick C.C. Maternal and lateral transmission of scrapie in sheep. J. Comp. Pathol. 1974;84:19–25. doi: 10.1016/0021-9975(74)90023-1. [DOI] [PubMed] [Google Scholar]
  131. Dickinson A.G., Fraser H., McConnell I., Outram G.W., Sales D.I., Taylor D.M. Extraneural competition between different scrapie agents leading to loss of infectivity. Nature. 1975;253:556. doi: 10.1038/253556a0. [DOI] [PubMed] [Google Scholar]
  132. Dickinson A.G., Fraser H., Outram G.W. Scrapie incubation time can exceed natural lifespan. Nature. 1975;256:732–733. doi: 10.1038/256732a0. [DOI] [PubMed] [Google Scholar]
  133. Diener T.O., McKinley M.P., Prusiner S.B. Vol. 79. 1982. Viroids and prions; pp. 5220–5224. (Proc. Natl. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  134. Dietrich J.F., Knopman D.S., List J.F., Olson K., Frey W.H., II, Emory C.R., Sung J.H., Haase A.T. Deletion in the prion protein gene in a demented patient. Hum. Mol. Gen. 1992;1:443–444. doi: 10.1093/hmg/1.6.443. [DOI] [PubMed] [Google Scholar]
  135. Diringer H. Sustained viremia in experimental hamster scrapie. Arch. Virol. 1984;82:105–109. doi: 10.1007/BF01309373. [DOI] [PubMed] [Google Scholar]
  136. Diringer H. Hidden Amyloidoses. Exper. Clinic. Immunogen. 1992;9:212–229. [PubMed] [Google Scholar]
  137. Diringer H., Ehlers B. Chemoprophylaxis of scrapie in mice. J. Gen. Virol. 1991;72:457–460. doi: 10.1099/0022-1317-72-2-457. [DOI] [PubMed] [Google Scholar]
  138. Diringer H., Rahn H.C., Bode L. Antibodies to protein of scrapie-associated fibrils. Lancet. 1984;2:345. doi: 10.1016/s0140-6736(84)92708-9. [DOI] [PubMed] [Google Scholar]
  139. Diringer H., Gelderblom H., Hilmert H., Özel M., Edelbluth C., Kimberlin R.H. Scrapie infectivity, fibrils and low molecular weight protein. Nature. 1983;306:476–478. doi: 10.1038/306476a0. [DOI] [PubMed] [Google Scholar]
  140. Dlouhy S.R., Hsiao K., Farlow M.R., Foroud T., Conneally P.M., Johnson P., Prusiner S.B., Hodes M.E., Ghetti B. Linkage of the Indiana kindred of Gerstmann-Sträussler-Scheinker disease to the prion protein gene. Nature Genetics. 1992;1:64–67. doi: 10.1038/ng0492-64. [DOI] [PubMed] [Google Scholar]
  141. Doh-ura K., Tateishi J., Sasaki H., Kitamoto T., Sakaki Y. Pro-leu change at position 102 of prion protein is the most common but not the sole mutation related to Gerstmann-Sträussler syndrome. Biochem. Biophys. Res. Commun. 1989;163:974–979. doi: 10.1016/0006-291x(89)92317-6. [DOI] [PubMed] [Google Scholar]
  142. Doh-ura K., Tateishi J., Kitamoto T., Sasaki H., Sakaki Y., Narang H.K., Perry R.H. Creutzfeldt-Jakob disease patients with congophilic kuru plaques have the missense variant prion protein common to Gerstmann-Sträussler syndrome. Ann. Neurol. 1990;335:663–664. doi: 10.1002/ana.410270205. [DOI] [PubMed] [Google Scholar]
  143. Doh-ura K., Kitamoto T., Sakaki Y., Tateishi J. CJD discrepancy. Nature. 1991;353:801–802. doi: 10.1038/353801b0. [DOI] [PubMed] [Google Scholar]
  144. Doi-Yi R., Kitamoto T., Tateishi J. Immunoreactivity of cerebral amyloidosis is enhanced by protein denaturation treatments. Acta Neuropathol. (Berl.) 1991;82:260–265. doi: 10.1007/BF00308810. [DOI] [PubMed] [Google Scholar]
  145. Dörig R.E., Marcil A., Chopra A., Richardson C.D. The human CD46 molecule is a receptor for measles virus (Edmonston strain) Cell. 1993;75:295–305. doi: 10.1016/0092-8674(93)80071-l. [DOI] [PubMed] [Google Scholar]
  146. Duchen L.W., Poulter M., Harding A.E. Dementia associated with a 216 base pair insertion in the prion protein gene. Clinical and neuropathological features. Brain. 1993;116:555–567. doi: 10.1093/brain/116.3.555. [DOI] [PubMed] [Google Scholar]
  147. Duffy P., Wolf J., Collins G., DeVoe A.G., Streeten B., Cowen D. Possible person-to-person transmission of Creutzfeldt-Jakob disease. N. Engl. J. Med. 1974;290:692–693. [PubMed] [Google Scholar]
  148. Duguid J.R., Rohwer R.G., Seed B. Vol. 85. 1988. Isolation of cDNAs of scrapie-modulated RNAs by subtractive hybridization of a cDNA library; pp. 5738–5742. (Proc. Natl. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  149. Ehlers B., Diringer H. Dextran sulphate 500 delays and prevents mouse scrapie by impairment of agent replication in spleen. J. Gen. Virol. 1984;65:1325–1330. doi: 10.1099/0022-1317-65-8-1325. [DOI] [PubMed] [Google Scholar]
  150. Ehlers B., Rudolph R., Diringer H. The reticuloendothelial system in scrapie pathogenesis. J. Gen. Virol. 1984;65:423–428. doi: 10.1099/0022-1317-65-2-423. [DOI] [PubMed] [Google Scholar]
  151. Eiden M.V., Farrell K., Warsowe J., Mahan L.C., Wilson C.A. Characterization of a naturally occurring ecotropic receptor that does not facilitate entry of all ecotropic murine retroviruses. J. Virol. 1993;67:4056–4061. doi: 10.1128/jvi.67.7.4056-4061.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  152. Endo T., Groth D., Prusiner S.B., Kobata A. Diversity of oligosaccharide structures linked to asparagines of the scrapie prion protein. Biochemistry. 1989;28:8380–8388. doi: 10.1021/bi00447a017. [DOI] [PubMed] [Google Scholar]
  153. Ernst D.R., Race R.E. Comparative analysis of scrapie agent inactivation methods. J. Virol. Methods. 1993;41:193–202. doi: 10.1016/0166-0934(93)90126-c. [DOI] [PubMed] [Google Scholar]
  154. Esmonde T., Lueck C.J., Symon L., Duchen L.W., Will R.G. Creutzfeldt-Jakob disease and lyophilised dura mater grafts: Report of two cases. J. Neurol. Neurosurg. Psychiatry. 1993;56:999–1000. doi: 10.1136/jnnp.56.9.999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  155. Farlow M.R., Yee R.D., Dlouhy S.R., Conneally P.M., Azzarelli B., Ghetti B. Gerstmann-Sträussler-Scheinker disease. I. Extending the clinical spectrum. Neurology. 1989;39:1446–1452. doi: 10.1212/wnl.39.11.1446. [DOI] [PubMed] [Google Scholar]
  156. Farmer P.M., Kane W.C., Hollenberg Sher J. Incidence of Creutzfeldt-Jakob disease in Brooklyn and Staten Island. N. Engl. J. Med. 1978;298:283–284. doi: 10.1056/NEJM197802022980523. [DOI] [PubMed] [Google Scholar]
  157. Farquhar C.F., Dickinson A.G. Prolongation of scrapie incubation period by an injection of dextran sulphate 500 within the month before or after infection. J. Gen. Virol. 1986;67:463–473. doi: 10.1099/0022-1317-67-3-463. [DOI] [PubMed] [Google Scholar]
  158. Fingeroth J.D., Weiss J.J., Tedder T.F., Strominger J.L., Biro P.A., Fearon T.D. Vol. 81. 1984. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2; pp. 4510–4514. (Proc. Natl. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  159. Fink J.K., Warren J.T.J., Drury I., Murman D., Peacock M.L. Allele-specific sequencing confirms novel prion gene polymorphism in Creutzfeldt-Jakob disease. Neurology. 1991;41:1647–1650. doi: 10.1212/wnl.41.10.1647. [DOI] [PubMed] [Google Scholar]
  160. Fleetwood A.J., Furley C.W. Spongiform encephalopathy in an eland. Vet. Rec. 1990;126:408–409. [PubMed] [Google Scholar]
  161. Foncin J., Gaches J., Cathala F., El Sharif E., Le Beau J. Transmission iatrogène interhumaine possible de maladie de Creutzfeldt-Jakob avec atteinte des grains du cervelet. Rev. Neurol. (Paris) 1980;136:280. [Google Scholar]
  162. Foote W.C., Clark W., Maciulis A., Call J.W., Hourrigan J., Evans R.C., Marshall M.R., De Camp M. Prevention of scrapie transmission in sheep, using embryo transfer. Am. J. Vet. Res. 1993;54:1863–1868. [PubMed] [Google Scholar]
  163. Forloni G., Angeretti N., Chiesa R., Monzani E., Salmona M., Bugiani O., Tagliavini F. Neurotoxicity of a prion protein fragment. Nature. 1993;362:543–546. doi: 10.1038/362543a0. [DOI] [PubMed] [Google Scholar]
  164. Foster J.D., Dickinson A.G. The unusual properties of CH1641, a sheep-passaged isolate of scrapie. Vet. Rec. 1988;123:5–8. doi: 10.1136/vr.123.1.5. [DOI] [PubMed] [Google Scholar]
  165. Foster J.D., Dickinson A.G. Age at death from natural scrapie in a flock of Suffolk sheep. Vet. Rec. 1989;125:415–417. doi: 10.1136/vr.125.16.415. [DOI] [PubMed] [Google Scholar]
  166. Foster J.D., McKelvey W.A.C., Mylne M.J.A., Williams A., Hunter N., Hope J., Fraser H. Studies on maternal trasmission of scrapie in sheep by embryo transfer. Vet. Rec. 1992;130:341–343. doi: 10.1136/vr.130.16.341. [DOI] [PubMed] [Google Scholar]
  167. Fradkin J.E., Schonberger L.B., Mills J.L., Gunn W.J., Piper J.M., Wysowski D.K., Thomson R., Durako S., Brown P. Creutzfeldt-Jakob disease in pituitary growth hormone recipients in the United States. JAMA. 1991;265:880–884. [PubMed] [Google Scholar]
  168. Fraser H. Diversity in the neuropathology of scrapie-like diseases in animals. Br. Med. Bull. 1993;49:792–809. doi: 10.1093/oxfordjournals.bmb.a072647. [DOI] [PubMed] [Google Scholar]
  169. Fraser H., Dickinson A.G. The sequential development of the brain lesion of scrapie in three strains of mice. J. Comp. Pathol. 1968;78:301–311. doi: 10.1016/0021-9975(68)90006-6. [DOI] [PubMed] [Google Scholar]
  170. Fraser H., Dickinson A.G. Pathogenesis of scrapie in the mouse: the role of the spleen. Nature. 1970;226:462–463. doi: 10.1038/226462a0. [DOI] [PubMed] [Google Scholar]
  171. Fraser H., Dickinson A.G. Scrapie in mice. Agent-strain differences in the distribution and intensity of grey matter vacuolation. J. Comp. Pathol. 1973;83:29–40. doi: 10.1016/0021-9975(73)90024-8. [DOI] [PubMed] [Google Scholar]
  172. Fraser H., Dickinson A.G. Studies of the lymphoreticular system in the pathogenesis of scrapie: the role of spleen and thymus. J. Comp. Pathol. 1978;88:563–573. doi: 10.1016/0021-9975(78)90010-5. [DOI] [PubMed] [Google Scholar]
  173. Fraser H., Farquhar C.F. Ionising radiation has no influence on scrapie incubation period in mice. Vet. Microbiol. 1987;13:211–223. doi: 10.1016/0378-1135(87)90084-8. [DOI] [PubMed] [Google Scholar]
  174. Fraser H., McConnell I., Wells G.A., Dawson M. Transmission of bovine spongiform encephalopathy to mice. Vet. Rec. 1988;123:472. doi: 10.1136/vr.123.18.472. [DOI] [PubMed] [Google Scholar]
  175. Fraser H., Bruce M.E., Chree A., McConnell I., Wells G.A.H. Trasmission of bovine spongiform encephalopathy and scrapie to mice. J. Gen. Virol. 1992;73:1891–1897. doi: 10.1099/0022-1317-73-8-1891. [DOI] [PubMed] [Google Scholar]
  176. Fraser H., Bruce M.E., Davies D., Farquhar C.F., McBride P.A. The lymphoreticular system in the pathogenesis of scrapie. In: Prusiner S.B., Collinge J., Powell J., Anderton B., editors. Prion Diseases of Humans and Animals. Ellis Horwood; New York: 1992. pp. 308–317. [Google Scholar]
  177. Furlow T.W.J., Whitley R.J., Wilmes F.J. Repeated suppression of Creutzfeldt-Jakob disease with vidarabine. Lancet. 1982;2:564–565. doi: 10.1016/s0140-6736(82)90652-3. [DOI] [PubMed] [Google Scholar]
  178. Gabizon R., Meiner Z., Halimi M., Ben-Sasson S.A. Heparin-like molecules bind differentially to prion-proteins and change their intracellular metabolic fate. J. Cell. Physiol. 1993;157:319–325. doi: 10.1002/jcp.1041570215. [DOI] [PubMed] [Google Scholar]
  179. Gabizon R., Rosenmann H., Meiner Z., Kahana I., Kahana E., Shugart Y., Ott J., Prusiner S.B. Mutation and polymorphism of the prion protein gene in Libyan Jews with Creutzfeldt-Jakob disease (CJD) Am. J. Hum. Genet. 1993;53:828–835. [PMC free article] [PubMed] [Google Scholar]
  180. Gabriel J.M., Oesch B., Kretzschmar H.A., Scott M., Prusiner S.B. Vol. 89. 1992. Molecular cloning of a candidate chicken prion protein; pp. 9097–9101. (Proc. Natl. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  181. Gajdusek D.C. Unconventional viruses and the origin and disappearance of kuru. Science. 1977;197:943–960. doi: 10.1126/science.142303. [DOI] [PubMed] [Google Scholar]
  182. Gajdusek D.C. Chronic dementia caused by small unconventional viruses apparently containing no nucleic acid. In: Scheibel A.B., Wechsler A.F., Brazier M.A., editors. The Biological Substrates of Alzheimer's Disease. Academic Press; New York: 1986. pp. 33–54. [Google Scholar]
  183. Gajdusek D.C. Transmissible amyloidoses of the brain. In: Liberski P.P., editor. Light and Electron Microscopic Neuropathology of Slow Virus Disorders. CRC Press; Boca Raton: 1993. pp. 1–31. [Google Scholar]
  184. Gajdusek D.C. Genetic control of nucleation and polymerization of host precursors to infectious amyloids in the transmissible amyloidoses of brain. Br. Med. Bull. 1993;49:913–931. doi: 10.1093/oxfordjournals.bmb.a072653. [DOI] [PubMed] [Google Scholar]
  185. Gajdusek D.C., Zigas V. Degenerative disease of the central nervous system in New Guinca. The endemic occurrence of “kuru” in the native population. N. Engl. J. Med. 1957;257:974–978. doi: 10.1056/NEJM195711142572005. [DOI] [PubMed] [Google Scholar]
  186. Gajdusek D.C., Gibbs C.J., Jr, Alpers M.P. Experimental transmission of a Kuru-like syndrome to chimpanzees. Nature. 1966;209:794–796. doi: 10.1038/209794a0. [DOI] [PubMed] [Google Scholar]
  187. Galvez S., Masters C.L., Gajdusek D.C. Descriptive epidemiology of Creutzfeldt-Jakob disease in Chile. Arch. Neurol. 1980;37:11–14. doi: 10.1001/archneur.1980.00500500041004. [DOI] [PubMed] [Google Scholar]
  188. Gasset M., Baldwin M.A., Lloyd D.H., Gabriel J.M., Holtzman D.M., Cohen F., Fletterick R.J., Prusiner S.B. Vol. 89. 1992. Predicted a-helical regions of the prion protein when synthesized as peptides form amyloid; pp. 10940–10944. (Proc. Natl. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  189. Gasset M., Baldwin M.A., Fletterick R.J., Prusiner S.B. Vol. 90. 1993. Perturbation of the secondary structure of the scrapie prion protein under conditions that alter infectivity; pp. 1–5. (Proc. Natl. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  190. Gerstmann J. Über ein noch nicht beschriebenes Reflexphänomen bei einer Erkrankung des zerebellären Systems. Wien. Med. Wochenschr. 1928;78:906–908. [Google Scholar]
  191. Gerstmann J., Sträussler E., Scheinker I. Über eine eigenartige hereditär-familiäre Erkrankung des Zentralnervensystems. Zugleich ein Beitrag zur Frage des vorzeitigen lokalen Alterns. Z. Neurol. 1936;154:736–762. [Google Scholar]
  192. Ghetti B., Tagliavini F., Masters C.L., Beyreuther K., Giaccone G., Verga L., Farlow M.R., Conneally P.M., Dlouhy S.R., Azzarelli B., Bugiani O. Gerstmann-Sträussler-Scheinker disease. II. Neurofibrillary tangles and plaques with PrP-amyloid coexist in an affected family. Neurology. 1989;39:1453–1461. doi: 10.1212/wnl.39.11.1453. [DOI] [PubMed] [Google Scholar]
  193. Gibbons R.A., Hunter G.D. Nature of the scrapie agent. Nature. 1967;215:1041–1043. doi: 10.1038/2151041a0. [DOI] [PubMed] [Google Scholar]
  194. Gibbs C.J., Jr, Gajdusek D.C. Experimental subacute spongiform virus encephalopathies in primates and other laboratory animals. Science. 1973;182:67–68. doi: 10.1126/science.182.4107.67. [DOI] [PubMed] [Google Scholar]
  195. Gibbs C.J., Jr, Gajdusek D.C., Asher D.M., Alpers M.P., Beck E., Daniel P.M., Matthews W.B. Creutzfeldt-Jakob disease (spongiform encephalopathy): transmission to the chimpanzee. Science. 1968;161:388–389. doi: 10.1126/science.161.3839.388. [DOI] [PubMed] [Google Scholar]
  196. Gibbs C.J., Jr, Gajdusek D.C., Amyx H. Strain variation in the viruses of Creutzfeldt-Jakob disease and kuru. In: Prusiner S.B., Hadlow W.J., editors. Volume 2. Academic Press; New York: 1979. pp. 87–110. (Slow Transmissible Diseases of the Nervous System). [Google Scholar]
  197. Gibbs C.J., Jr, Amyx H.L., Bacote A., Masters C.L., Gajdusek D.C. Oral transmission of kuru, Creutzfeldt-Jakob disease and scrapie to nonhuman primates. J. Infect. Dis. 1980;142:205–208. doi: 10.1093/infdis/142.2.205. [DOI] [PubMed] [Google Scholar]
  198. Gibbs C.J., Jr, Joy A., Heffner R., Franko M., Miyazaki M., Asher D.M., Parisi J.E., Brown P.W., Gajdusek D.C. Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone. N. Engl. J. Med. 1985;313:734–738. doi: 10.1056/NEJM198509193131207. [DOI] [PubMed] [Google Scholar]
  199. Goldfarb L.G., Korczyn A.D., Brown P., Chapman J., Gajdusek D.C. Mutation in codon 200 of scrapie amyloid precursor gene linked to Creutzfeldt-Jakob disease in Sephardic Jews of Libyan and non-Libyan origin. Lancet. 1990;336:637–638. doi: 10.1016/0140-6736(90)93443-s. [DOI] [PubMed] [Google Scholar]
  200. Goldfarb L.G., Mitrova E., Brown P., Toh B.H., Gajdusek D.C. Mutation in codon 200 of scrapie amyloid protein gene in two clusters of Creutzfeldt-Jakob disease in Slovakia. Lancet. 1990;336:514–515. doi: 10.1016/0140-6736(90)92073-q. [DOI] [PubMed] [Google Scholar]
  201. Goldfarb L.G., Brown P., McCombie W.R., Goldgaber D., Swergold G.D., Wills P.R., Cervenáková L., Baron H., Gibbs C.J., Jr, Gajdusek D.C. Vol. 88. 1991. Transmissible familial Creutzfeldt-Jakob disease associated with five, seven and eight extra octapeptide coding repeats in the PRNP gene; pp. 10926–10930. (Proc. Natl. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  202. Goldfarb L.G., Brown P., Mitrova E., Cervenáková L., Goldin L., Korczyn A.D., Chapman J., Galvez S., Cartier L., Rubenstein R., Gajdusek D.C. Creutzfeldt-Jakob disease associated with the PRNP codon 200Lys mutation: an analysis of 45 families. Eur. J. Epidemiol. 1991;7:477–486. doi: 10.1007/BF00143125. [DOI] [PubMed] [Google Scholar]
  203. Goldfarb L.G., Haltia M., Brown P., Nieto A., Kovanen J., McCombie W.R., Trapp S., Gajdusek D.C. New mutation in scrapie amyloid precursor gene (at codon 178) in Finnish Creutzfeldt-Jakob kindred. Lancet. 1991;337:425. doi: 10.1016/0140-6736(91)91198-4. [DOI] [PubMed] [Google Scholar]
  204. Goldfarb L.G., Brown P., Haltia M., Cathala F., McCombie W.R., Kovanen J., Cervenáková L., Goldin L., Nieto A., Godec M.S., Asher D.M., Gajdusek D.C. Creutzfeldt-Jakob disease cosegregates with the codon 178 ASN PRNP mutation in families of european origin. Ann. Neurol. 1992;31:274–281. doi: 10.1002/ana.410310308. [DOI] [PubMed] [Google Scholar]
  205. Goldfarb L.G., Petersen R.B., Tabaton M., Brown P., LeBlanc A.C., Montagna P., Cortelli P., Julien J., Vital C., Pendelbury W.W., Haltia M., Wills P.R., Hauw J.J., McKeever P.E., Monari L., Schrank B., Swergold G.D., Autilio-Gambetti L., Gajdusek D.C., Lugaresi E., Gambetti P. Fatal familial insomnia and familial Creutzfeldt-Jakob Disease: disease phenotype detemined by a DNA polymorphism. Science. 1992;258:806–808. doi: 10.1126/science.1439789. [DOI] [PubMed] [Google Scholar]
  206. Goldfarb L.G., Brown P., Haltia M., Ghiso J., Frangione B., Gajdusek D.C. Vol. 90. 1993. Synthetic peptides corresponding to different mutated regions of the amyloid gene in familial Creutzfeldt-Jakob disease show enhanced in vitro formation of morphologically different amyloid fibrils; pp. 4451–4454. (Proc. Natl. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  207. Goldfarb L.G., Brown P., Little B.W., Cervenáková L., Kenney K., Gibbs C.J., Jr, Gajdusek D.C. A new (two-repeat) octapeptide coding insert mutation in Creutzfeldt-Jakob disease. Neurology. 1993;43:2392–2394. doi: 10.1212/wnl.43.11.2392. [DOI] [PubMed] [Google Scholar]
  208. Goldhammer Y., Bubis J.J., Sarova Pinhas I., Braham J. Subacute spongiform encephalopathy and its relation to Jakob-Creutzfeldt disease: report on six cases. J. Neurol. Neurosurg. Psychiatry. 1972;35:1–10. doi: 10.1136/jnnp.35.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  209. Goldhammer Y., Gabizon R., Meiner Z., Sadeh M. An Israeli family with Gerstmann-Sträussler-Scheinker disease manifesting the codon 102 mutation in the prion protein gene. Neurology. 1993;43:2718–2719. doi: 10.1212/wnl.43.12.2718. [DOI] [PubMed] [Google Scholar]
  210. Goldmann W. PrP gene and its association with spongiform encephalopathies. Br. Med. Bull. 1993;49:839–859. doi: 10.1093/oxfordjournals.bmb.a072650. [DOI] [PubMed] [Google Scholar]
  211. Goldmann W., Hunter N., Foster J.D., Salbaum J.M., Beyreuther K., Hope J. Vol. 87. 1990. Two alleles of a neural protein gene linked to scrapie in sheep; pp. 2476–2480. (Proc. Natl. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  212. Goldmann W., Hunter N., Benson G., Foster J.D., Hope J. Different scrapie-associated fibril proteins (PrP) are encoded by lines of sheep selected for different alleles of the Sip gene. J. Gen. Virol. 1991;72:2411–2417. doi: 10.1099/0022-1317-72-10-2411. [DOI] [PubMed] [Google Scholar]
  213. Goldmann W., Hunter N., Martin T., Dawson M., Hope J. Different forms of the bovine PrP gene have five or six copies of a short, G-C-rich element within the protein-coding exon. J. Gen. Virol. 1991;72:201–204. doi: 10.1099/0022-1317-72-1-201. [DOI] [PubMed] [Google Scholar]
  214. Gomi H., Ikeda T., Kunieda T., Itohara S., Prusiner S.B., Yamanouchi K. Prion protein (PrP) is not involved in the pathogenesis of spongiform encephalogpathy in zitter rats. Neurosci. Lett. 1994;166:171–174. doi: 10.1016/0304-3940(94)90478-2. [DOI] [PubMed] [Google Scholar]
  215. Gordon W.S. Advances in veterinary research. Louping-ill, tick-borne fever and scrapie. Vet. Rec. 1946;58:516–520. [PubMed] [Google Scholar]
  216. Gorman D.G., Benson D.F., Vogel D.G., Vinters H.V. Creutzfeldt-Jakob disease in a pathologist. Neurology. 1992;42:463. doi: 10.1212/wnl.42.2.463. [DOI] [PubMed] [Google Scholar]
  217. Greve J.M., Davis G., Meyer A.M., Forte C.P., Connolly Yost S., Marlor C.W., Kamarck M.E., McClelland A. The major human rhinovirus receptor is ICAM-1. Cell. 1989;56:839–847. doi: 10.1016/0092-8674(89)90688-0. [DOI] [PubMed] [Google Scholar]
  218. Griffith J.S. Self-replication and scrapie. Nature. 1967;215:1043–1044. doi: 10.1038/2151043a0. [DOI] [PubMed] [Google Scholar]
  219. Guiroy D.C., Williams E.S., Song K.-J., Yanagihara R., Gajdusek D.C. Fibrils in brains of Rocky Mountain elk with chronic wasting disease contain scrapie amyloid. Acta Neuropathol. (Berl.) 1993;86:77–80. doi: 10.1007/BF00454902. [DOI] [PubMed] [Google Scholar]
  220. Hadlow W.J., Kennedy R.C., Race R.E., Eklund C.M. Virologic and neurohistologic findings in dairy goats affected with natural scrapie. Vet. Pathol. 1980;17:187–199. doi: 10.1177/030098588001700207. [DOI] [PubMed] [Google Scholar]
  221. Hadlow W.J., Kennedy R.C., Race R.E. Natural infection of Suffolk sheep with scrapie virus. J. Infect. Dis. 1982;146:657–664. doi: 10.1093/infdis/146.5.657. [DOI] [PubMed] [Google Scholar]
  222. Haltia M., Kovanen J., Goldfarb L.G., Brown P., Gajdusek D.C. Familial Creutzfeldt-Jakob disease in Finland: epidemiological, clinical, pathological and molecular genetic studies. Eur. J. Epidemiol. 1991;7:494–500. doi: 10.1007/BF00143128. [DOI] [PubMed] [Google Scholar]
  223. Haraguchi T., Fisher S., Olofsson S., Endo T., Groth D., Tarentino A., Borchelt D.R., Teplow D., Hood L., Burlingame A., Lycke E., Kobata A., Prusiner S.B. Asparagine-linked glycosylation of the scrapie and cellular prion proteins. Arch. Biochem. Biophys. 1989;274:1–13. doi: 10.1016/0003-9861(89)90409-8. [DOI] [PubMed] [Google Scholar]
  224. Harries Jones R., Knight R., Will R.G., Cousens S.N., Smith P.G., Matthews W.B. Creutzfeldt-Jakob disease in England and Wales, 1980–1984: a case-control study of potential risk factors. J. Neurol. Neurosurg. Psychiatry. 1988;51:1113–1119. doi: 10.1136/jnnp.51.9.1113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  225. Harrington M.G., Merril C.R., Asher D.M., Gajdusek D.C. Abnormal proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. N. Engl. J. Med. 1986;315:279–283. doi: 10.1056/NEJM198607313150502. [DOI] [PubMed] [Google Scholar]
  226. Hartsough G.R., Burger D. Encephalopathy of mink. I. Epizootiologic and clinical observations. J. Infect. Dis. 1965;115:387–392. doi: 10.1093/infdis/115.4.387. [DOI] [PubMed] [Google Scholar]
  227. Hashimoto K., Mannen T., Nukina N. Immunohistochemical study of kuru plaques using antibodies against synthetic prion protein peptides. Acta Neuropathol. (Berl.) 1992;83:613–617. doi: 10.1007/BF00299410. [DOI] [PubMed] [Google Scholar]
  228. Haun G., Keppler O.T., Bock C.T., Herrmann M., Zentgraf H., Pawlita M. The cell surface receptor is a major determinant restricting the host range of the B-lymphotropic papovavirus. J. Virol. 1993;67:7482–7492. doi: 10.1128/jvi.67.12.7482-7492.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  229. Haywood A.M. Virus receptors: Binding, adhesion strengthening and changes in viral structure. J. Virol. 1994;68:1–5. doi: 10.1128/jvi.68.1.1-5.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  230. Hecker R., Taraboulos A., Scott M., Pan K.M., Yang S.L., Torchia M., Jendroska K., DeArmond S.J., Prusiner S.B. Replication of distinet scrapie prion isolates is region specific in brains of transgenic mice and hamsters. Genes Dev. 1992;6:1213–1228. doi: 10.1101/gad.6.7.1213. [DOI] [PubMed] [Google Scholar]
  231. Herishanu Y. Antiviral drugs in Jakob-Creutzfeldt disease. J. Am. Geriatr. Soc. 1973;21:229–231. doi: 10.1111/j.1532-5415.1973.tb01676.x. [DOI] [PubMed] [Google Scholar]
  232. Hitoshi S., Nagura H., Yamanouchi H., Kitamoto T. Double mutations at codon 180 and codon 232 of the PRNP gene in an apparently sporadic case of Creutzfeldt-Jakob disease. J. Neurol. Sci. 1993;120:208–212. doi: 10.1016/0022-510x(93)90275-4. [DOI] [PubMed] [Google Scholar]
  233. Hope J., Baybutt H. The key role of the nerve membrane in the scrapie like disease. Semin. Neurosci. 1991;3:165–171. [Google Scholar]
  234. Hope J., Morton L.J., Farquhar C.F., Multhaup G., Beyreuther K., Kimberlin R.H. The major polypeptide of scrapie-associated fibrils (SAF) has the same size, charge distribution and N-terminal protein sequence as predicted for the normal brain protein (PrP) EMBO J. 1986;5:2591–2597. doi: 10.1002/j.1460-2075.1986.tb04539.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  235. Hope J., Malthaup G., Reekie L.J., Kimberlin R.H., Beyreuther K. Molecular pathology of scrapie-associated fibril protein (PrP) in mouse brain affected by the ME7 strain of scrapie. Eur. J. Biochem. 1988;172:271–277. doi: 10.1111/j.1432-1033.1988.tb13883.x. [DOI] [PubMed] [Google Scholar]
  236. Hope J., Reekie L.J., Hunter N., Multhaup G., Beyreuther K., White H., Scott A.C., Stack M.J., Dawson M., Wells G.A. Fibrils from brains of cows with new cattle disease contain scrapie-associated protein. Nature. 1988;336:390–392. doi: 10.1038/336390a0. [DOI] [PubMed] [Google Scholar]
  237. Horie H., Koike S., Kurata T., Sato-Yoshida Y., Ise I., Ota Y., Abe S., Hioki K., Kato H., Taya C., Nomura T., Hashizume S., Yonekawa H., Nomoto A. Transgenic mice carrying the human poliovirus receptor: New animal model for study of poliovirus neurovirulence. J. Virol. 1994;68:681–688. doi: 10.1128/jvi.68.2.681-688.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  238. Hourrigan J., Klingsporn A., Clark W.W., De Camp M. Epidemiology of scrapie in the United States. In: Prusiner S.B., Hadlow W.J., editors. Vol. 1. Academic Press; New York: 1979. pp. 331–356. (Slow Transmissible Diseases of the Nervous System). [Google Scholar]
  239. Hourrigan J.L. Experimentally induced bovine spongiform encephalopathy in cattle in Mission, Tex and the control of scrapie. J. Am. Vet. Med. Assoc. 1990;196:1678–1679. [PubMed] [Google Scholar]
  240. Hsiao K., Baker H.F., Crow T.J., Poulter M., Owen F., Terwilliger J.D., Westaway D., Ott J., Prusiner S.B. Linkage of a prion protein missense variant to Gerstmann-Sträussler syndrome. Nature. 1989;338:342–345. doi: 10.1038/338342a0. [DOI] [PubMed] [Google Scholar]
  241. Hsiao K.K., Scott M., Foster D., Groth D.F., DeArmond S.J., Prusiner S.B. Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science. 1990;250:1587–1590. doi: 10.1126/science.1980379. [DOI] [PubMed] [Google Scholar]
  242. Hsiao K., Mfiner Z., Kahana E., Cass C., Kahana I., Avrahami D., Scarlato G., Abramsky O., Prusiner S.B., Gabizon R. Mutation of the prion protein in libyan Jews with Creutzfeldt-Jakob disease. N. Engl. J. Med. 1991;324:1091–1097. doi: 10.1056/NEJM199104183241604. [DOI] [PubMed] [Google Scholar]
  243. Hsiao K.K., Cass C., Schellenberg G.D., Bird T., Devine Gage E., Wisniewski H., Prusiner S.B. A prion protein variant in a family with the telencephalic form of Gerstmann-Sträussler-Scheinker syndrome. Neurology. 1991;41:681–684. doi: 10.1212/wnl.41.5.681. [DOI] [PubMed] [Google Scholar]
  244. Hsiao K., Dlouhy S.R., Farlow M.R., Cass C., Da Costa M., Conneally P.M., Hodes M.E., Ghetti B., Prusiner S.B. Mutant prion protein in Gerstmann-Sträussler-Scheinker disease with neurofibrillary tangles. Nature Genet. 1992;1:68–71. doi: 10.1038/ng0492-68. [DOI] [PubMed] [Google Scholar]
  245. Hsiao K.K., Groth D., Scott M., Yang S.L., Serban A., Rapp D., Foster D., Torchia M., DeArmond S.J., Prusiner S.B. Genetic and transgenic studies of prion proteins in Gerstmann-Sträussler-Scheinker disease. In: Prusiner S.B., Collinge J., Powell J., Anderton B., editors. Prion Diseases of Humans and Animals. Ellis Horwood; New York: 1992. pp. 120–128. [Google Scholar]
  246. Hunter N., Hope J., McConnell I., Dickinson A.G. Linkage of the scrapie-associated fibril protein (PrP) gene and Sinc using congenic mice and restriction fragment length polymorphism analysis. J. Gen. Virol. 1987;68:2711–2716. doi: 10.1099/0022-1317-68-10-2711. [DOI] [PubMed] [Google Scholar]
  247. Hunter N., Goldmann W., Benson G., Foster J.D., Hope J. Swaledale sheep affected by natural scrapie differ significantly in PrP genotype frequencies from healthy sheep and those selected for reduced incidence of scrapie. J. Gen. Virol. 1993;74:1025–1031. doi: 10.1099/0022-1317-74-6-1025. [DOI] [PubMed] [Google Scholar]
  248. Inoue I., Kitamoto T., Doh-ura K., Shii H., Goto I., Tateishi J. Japanese family with Creutzfeldt-Jakob disease with codon 200 point mutation of the prion protein gene. Neurology. 1994;44:299–301. doi: 10.1212/wnl.44.2.299. [DOI] [PubMed] [Google Scholar]
  249. Isomura H., Shinagawa M., Ikegami Y., Sasaki K., Ishiguro N. Morphological and biochemical evidence that scrapie-associated fibrils are derived from aggregated amyloid-like filaments. Virus Res. 1991;18:191–201. doi: 10.1016/0168-1702(91)90018-q. [DOI] [PubMed] [Google Scholar]
  250. Iwasaki M., Okumura K., Kondo Y., Tanaka T., Igarashi H. cDNA cloning of a novel heterogeneous nuclear ribonucleoprotein gene homologue in Caenorhabditis-elegans using hamster prion protein cDNA as a hybridization probe. Nucleic Acids Res. 1992;20:4001–4007. doi: 10.1093/nar/20.15.4001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  251. Jakob A. Über eine der multiplen Sklerose klinisch nahestehenden Erkrankung des Zentralnervensystems (spastische Pseudosklerose) mit bemerkenswertem anatomischen Befunde. Med. Klin. 1921;13:372–376. [Google Scholar]
  252. Jakob A. Über eigenartige Erkrankungen des Zentralnervensystems mit bemerkenswertem anatomischen Befunde (Spastische Pseudosklerose-Encephalomyelopathie mit disseminierten Degenerationsherden) Deut. Z. Nervenheilk. 1921;70:132–146. [Google Scholar]
  253. Jakob A. Über eigenartige Erkrankungen des Zentranervensystems mit bemerkenswertem anatomischen Befunde (Spastische Pseudosklerose-Encephalomyelopathie mit disseminierten Degenerationsherden) Z. ges. Neurol. Psychiat. 1921;64:147–228. [Google Scholar]
  254. Janssen R.S., Schonberger L.B. Creutzfeldt-Jakob disease from allogeneic Duraa review of risks and safety. J. Oral Maxillofac. Surg. 1991;49:274–275. doi: 10.1016/0278-2391(91)90218-b. [DOI] [PubMed] [Google Scholar]
  255. Jeffrey M., Wells G.A. Spongiform encephalopathy in a nyala (Tragelaphus angasi) Vet. Pathol. 1988;25:398–399. doi: 10.1177/030098588802500514. [DOI] [PubMed] [Google Scholar]
  256. Jellinger K., Seitelberger F., Heiss W.D. Konjugale Form der subacuten spongiösen Enzephalopathie (Jakob-Creutzfeldt-Erkrankung) Wien Klin. Wochenschr. 1972;84:245–249. [PubMed] [Google Scholar]
  257. Kahana E., Alter M., Braham J., Sofer D. Creutzfeldt-Jakob disease: focus among Libyan Jews in Israel. Science. 1974;183:90–91. doi: 10.1126/science.183.4120.90. [DOI] [PubMed] [Google Scholar]
  258. Kellings K., Meyer N., Mirenda C.A., Prusiner S.B., Riesner D. Further analysis of nucleic acids in purified scrapie prion preparations by improved return refocusing gel electrophoresis. J. Gen. Virol. 1992;73:1025–1029. doi: 10.1099/0022-1317-73-4-1025. [DOI] [PubMed] [Google Scholar]
  259. Kimberlin R.H. Experimental scrapie in the mouse: a review of an important model disease. Sci. Prog. 1976;63:461–481. [PubMed] [Google Scholar]
  260. Kimberlin R.H. Scrapie and possible relationships with viroids. Semin. Virol. 1990;1:153–162. [Google Scholar]
  261. Kimberlin R.H. Bovine spongiform encephalopathy: An appraisal of the current epidemic in the United Kingdom. Intervirology. 1993;35:208–218. doi: 10.1159/000150311. [DOI] [PubMed] [Google Scholar]
  262. Kimberlin R.H., Walker C.A. Pathogenesis of mouse scrapie: effect of route of inoculation on infectivity titres and dose-response curves. J. Comp. Pathol. 1978;88:39–47. doi: 10.1016/0021-9975(78)90059-2. [DOI] [PubMed] [Google Scholar]
  263. Kimberlin R.H., Walker C.A. Evidence that the transmission of one source of scrapie agent to hamsters involves separation of agent strains from a mixture. J. Gen. Virol. 1978;39:487–496. doi: 10.1099/0022-1317-39-3-487. [DOI] [PubMed] [Google Scholar]
  264. Kimberlin R.H., Walker C.A. Pathogenesis of mouse scrapie: dynamics of agent replication in spleen, spinal cord and brain after infection by different routes. J. Comp. Pathol. 1979;89:551–562. doi: 10.1016/0021-9975(79)90046-x. [DOI] [PubMed] [Google Scholar]
  265. Kimberlin R.H., Walker C.A. Antiviral compound effective against experimental scrapie. Lancet. 1979;2:591–592. doi: 10.1016/s0140-6736(79)91654-4. [DOI] [PubMed] [Google Scholar]
  266. Kimberlin R.H., Walker C.A. Invasion of the CNS by scrapie agent and its spread to different parts of the brain. In: Court L.A., Cathala F., editors. Virus non Conventionnels et Affections du Systeme Nerveux Central. Masson; Paris: 1983. pp. 17–23. [Google Scholar]
  267. Kimberlin R.H., Walker C.A. Competition between strains of scrapie depends on the blocking agent being infections. Intervirology. 1985;23:74–81. doi: 10.1159/000149588. [DOI] [PubMed] [Google Scholar]
  268. Kimberlin R.H., Walker C.A. Pathogenesis of scrapie (strain 263K) in hamsters infected intracerebrally, intraperitoneally or intraocularly. J. Gen. Virol. 1986;67:255–263. doi: 10.1099/0022-1317-67-2-255. [DOI] [PubMed] [Google Scholar]
  269. Kimberlin R.H., Walker C.A. Suppression of scrapie infection in mice by heteropolyanion 23, dextran sulfate, and some other polyanions. Antimicrob. Agents Chemother. 1986;30:409–413. doi: 10.1128/aac.30.3.409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  270. Kimberlin R.H., Walker C.A. Vol. 135. 1988. Pathogenesis of experimental scrapie; pp. 37–62. (Ciba Found. Symp.). [DOI] [PubMed] [Google Scholar]
  271. Kimberlin R.H., Walker C.A. Pathogenesis of scrapie in mice after intragastric infection. Virus Res. 1989;12:213–220. doi: 10.1016/0168-1702(89)90040-3. [DOI] [PubMed] [Google Scholar]
  272. Kimberlin R.H., Walker C.A., Millson G.C., Taylor D.M., Robertson P.A., Tomlinson A.H., Dickinson A.G. Disinfection studies with two strains of mouse-passaged scrapie agent. Guidelines for Creutzfeldt-Jakob and related agents. J. Neurol. Sci. 1983;59:355–369. doi: 10.1016/0022-510x(83)90021-7. [DOI] [PubMed] [Google Scholar]
  273. Kimberlin R.H., Cole S., Walker C.A. Transmissible mink encephalopathy (TME) in Chinese hamsters: identification of two strains of TME and comparisons with scrapie. Neuropathol. Appl. Neurobiol. 1986;12:197–206. doi: 10.1111/j.1365-2990.1986.tb00050.x. [DOI] [PubMed] [Google Scholar]
  274. Kimberlin R.H., Cole S., Walker C.A. Pathogenesis of scrapie is faster when infection is intraspinal instead of intracerebral. Microb. Pathog. 1987;2:405–415. doi: 10.1016/0882-4010(87)90047-7. [DOI] [PubMed] [Google Scholar]
  275. Kimberlin R.H., Walker C.A., Fraser H. The genomic identity of different strains of mouse scrapie is expressed in hamsters and preserved on reisolation in mice. J. Gen. Virol. 1989;70:2017–2025. doi: 10.1099/0022-1317-70-8-2017. [DOI] [PubMed] [Google Scholar]
  276. Kirkwood J.K., Wells G.A., Wilesmith J.W., Cunningham A.A., Jackson S.I. Spongiform encephalopathy in an arabian oryx (Oryx leucoryx) and a greater kudu (Tragelaphus strepsiceros) Vet. Rec. 1990;127:418–420. [PubMed] [Google Scholar]
  277. Kitamoto T., Tateishi J. Immunohistochemical confirmation of Creutzfeldt-Jakob disease with a long clinical course with amyloid plaque core antibodies. Am. J. Pathol. 1988;131:435–443. [PMC free article] [PubMed] [Google Scholar]
  278. Kitamoto T., Yi R., Mohri S., Tateishi J. Cerebral amyloid in mice with Creutzfeldt-Jakob disease is influenced by the strain of the infectious agent. Brain Res. 1990;508:165–167. doi: 10.1016/0006-8993(90)91132-z. [DOI] [PubMed] [Google Scholar]
  279. Kitamoto T., Muramoto T., Mohri S., Doh-ura K., Tateishi J. Abnormal isoform of prion protein accumulates in follicular dendritic cells in mice with Creutzfeldt-Jakob disease. J. Virol. 1991;65:6292–6295. doi: 10.1128/jvi.65.11.6292-6295.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  280. Kitamoto T., Amano N., Terao Y., Nakazato Y., Isshiki T., Mizutani T., Tateishi J. A new inherited prion disease (PrP-P105L mutation) showing spastic paraparesis. Ann. Neurol. 1993;34:808–813. doi: 10.1002/ana.410340609. [DOI] [PubMed] [Google Scholar]
  281. Kitamoto T., Iizuka R., Tateishi J. An amber mutation of prion protein in Gerstmann-Sträussler syndrome with mutant PrP plaques. Biochem. Biophys. Res. Commun. 1993;192:525–531. doi: 10.1006/bbrc.1993.1447. [DOI] [PubMed] [Google Scholar]
  282. Kitamoto T., Ohta M., Doh-ura K., Hitoshi S., Terao Y., Tateishi J. Novel missense variants of prion protein in Creutzfeldt-Jakob disease or Gerstmann-Sträussler syndrome. Biochem. Biophys. Res. Commun. 1993;191:709–714. doi: 10.1006/bbrc.1993.1275. [DOI] [PubMed] [Google Scholar]
  283. Klatzman D., Champagne E., Chamaret S., Gruest J., Guetard D., Hercend T., Gluckman J.C., Montagnier L. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature. 1984;312:767–768. doi: 10.1038/312767a0. [DOI] [PubMed] [Google Scholar]
  284. Knipe D.M. Virus-host-cell interactions. In: Fields B.N., Knipe D.M., editors. Virology. Raven Press; New York: 1990. pp. 293–316. [Google Scholar]
  285. Koch T.K., Berg B.O., DeArmond S.J., Gravina R.F. Creutzfeldt-Jakob disease in a young adult with idiopathic hypopituitarism. Possible relation to the administration of cadaveric human growth hormone. N. Engl. J. Med. 1985;313:731–733. doi: 10.1056/NEJM198509193131206. [DOI] [PubMed] [Google Scholar]
  286. Koike S., Taya C., Kurata T., Abe S., Ise I., Yonekawa H., Nomoto A. Vol. 88. 1991. Transgenic mice susceptible to poliovirus; pp. 951–955. (Proc. Natl. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  287. Kondo K., Kuroiwa Y. A case control study of Creutzfeldt-Jakob disease: association with physical injuries. Ann. Neurol. 1982;11:377–381. doi: 10.1002/ana.410110410. [DOI] [PubMed] [Google Scholar]
  288. Kretzschmar H.A., Prusiner S.B., Stowring L.E., DeArmond S.J. Scrapie prion proteins are synthesized in neurons. Am. J. Pathol. 1986;122:1–5. [PMC free article] [PubMed] [Google Scholar]
  289. Kretzschmar H.A., Stowring L.E., Westaway D., Stubblebine W.H., Prusiner S.B., DeArmond S.J. Molecular cloning of a human prion protein cDNA. DNA. 1986;5:315–324. doi: 10.1089/dna.1986.5.315. [DOI] [PubMed] [Google Scholar]
  290. Kretzschmar H.A., Honold G., Seitelberger F., Feucht M., Wessely P., Mehraein P., Budka H. Prion protein mutation first reported by Gerstmann, Sträussler and Scheinker. Lancet. 1991;337:1160. doi: 10.1016/0140-6736(91)92826-n. [DOI] [PubMed] [Google Scholar]
  291. Kretzschmar H.A., Kufer P., Riethmuller G., DeArmond S.J., Prusiner S.B., Schiffer D. Prion protein mutation at codon 102 in an Italian family with Gerstmann-Sträussler-Scheinker syndrome. Neurology. 1992;42:809–810. doi: 10.1212/wnl.42.4.809. [DOI] [PubMed] [Google Scholar]
  292. Kretzschmar H.A., Neumann M., Riethmuller G., Prusiner S.B. Molecular cloning of a mink prion protein gene. J. Gen. Virol. 1992;73:2757–2761. doi: 10.1099/0022-1317-73-10-2757. [DOI] [PubMed] [Google Scholar]
  293. Ladogana A., Casaccia P., Ingrosso L., Cibati M., Salvatore M., Xi Y.G., Masullo C., Pocchiari M. Sulphate polyanions prolong the incubation period of scrapie-infected hamsters. J. Gen. Virol. 1992;73:661–665. doi: 10.1099/0022-1317-73-3-661. [DOI] [PubMed] [Google Scholar]
  294. Laplanche J.L., Chatelain J., Launay J.M., Gazengel C., Vidaud M. Deletion in prion protein gene in a Moroccan family. Nucleic Acids Res. 1990;18:6745. doi: 10.1093/nar/18.22.6745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  295. Laplanche J.L., Chatelain J., Thomas S., Brown P., Cathala F. Analyse du gene PrP dans une famille d'origine Tunisienne atteinte de maladie de Creutzfeldt-Jakob. Rev. Neurol. (Paris) 1991;147:825–827. [PubMed] [Google Scholar]
  296. Laplanche J.L., Chatelain J., Westaway D., Thomas S., Dussaucy M., Brugere-Picoux J., Launay J.M. PrP polymorphisms associated with natural scrapie discovered by denaturing gradient gel electrophoresis. Genomics. 1993;15:30–37. doi: 10.1006/geno.1993.1006. [DOI] [PubMed] [Google Scholar]
  297. Lentz T.L. The recognition event between virus and host cell receptor: a target for antiviral agents. J. Gen. Virol. 1990;71:751–766. doi: 10.1099/0022-1317-71-4-751. [DOI] [PubMed] [Google Scholar]
  298. Lewin B. IV. Oxford University Press; New York: 1990. (Genes). [Google Scholar]
  299. Liberski P.P., Budka H. An overview of neuropathology of the slow unconventional virus infections. In: Liberski P.P., editor. Light and Electron Microscopic Neuropathology of Slow Virus Disorders. CRC Press; Boca Raton: 1993. pp. 111–153. [Google Scholar]
  300. Liberski P.P., Guiroy D.C., Williams E.S., Yanagihara R., Brown P., Gajdusek D.C. The amyloid plaque. In: Liberski P.P., editor. Light and Electron Microscopic Neuropathology of Slow Virus Disorders. CRC Press; Boca Raton: 1993. pp. 295–347. [Google Scholar]
  301. Liberski P.P., Guiroy D.C., Yanagihara R., Wells G.A.H., Gajdusek D.C. Astrocytic changes. In: Liberski P.P., editor. Light and Electron Microscopic Neuropathology of Slow Virus Disorders. CRC Press; Boca Raton: 1993. pp. 187–232. [Google Scholar]
  302. Liberski P.P., Nerurkar V., Yanahigara R., Gajdusek D.C. Immuno-histochemistry of astrocytic reaction. In: Liberski P.P., editor. Light and Electron Microscopic Neuropathology of Slow Virus Disorders. CRC Press; Boca Raton: 1993. pp. 233–250. [Google Scholar]
  303. Liberski P.P., Yanahigara R., Gajdusek D.C. The spongiform vacuole — the hallmark of slow virus diseases. In: Liberski P.P., editor. Light and Electron Microscopic Neuropathology of Slow Virus Disorders. CRC Press; Boca Raton: 1993. pp. 155–180. [Google Scholar]
  304. Lieberburg I. Developmental expression and regional distribution of the scrapie-associated protein mRNA in the rat central nervous system. Brain Res. 1987;417:363–366. doi: 10.1016/0006-8993(87)90465-3. [DOI] [PubMed] [Google Scholar]
  305. Lo Russo F., Neri G., FigàTalamanca L. Creutzfeldt-Jakob disease and sheep brain. A report from Central and Southern Italy. Ital. J. Neurol. Sci. 1980;3:171–174. doi: 10.1007/BF02335847. [DOI] [PubMed] [Google Scholar]
  306. Locht C., Chesebro B., Race R.E., Keith J.M. Vol. 83. 1986. Molecular cloning and complete sequence of prion protein cDNA from mouse brain infected with the scrapie agent; pp. 6372–6376. (Proc. Natl. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  307. Lowenstein D.H., Butler D.A., Westaway D., McKinley M.P., DeArmond S.J., Prusiner S.B. Three hamster species with different scrapie incubation times and neuropathological features encode distinct prion proteins. Mol. Cell. Biol. 1990;10:1153–1163. doi: 10.1128/mcb.10.3.1153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  308. Lugaresi E., Medori R., Montagna P., Baruzzi A., Cortelli P., Lugaresi A., Tinuper P., Zucconi M., Gambetti P. Fatal Familial Insomnia and Dysautonomia with selective degeneration of thalamic nuclei. N. Engl. J. Med. 1986;315:997–1003. doi: 10.1056/NEJM198610163151605. [DOI] [PubMed] [Google Scholar]
  309. Maciulis A., Hunter N., Wang S., Goldman W., Hope J., Foote W. Polymorphism of a scrapie-associated fibril protein (PrP) gene and their association with susceptibility to experimentally induced scrapie in Cheviot sheep in the United States. Am. J. Vet. Res. 1992;53:1957–1960. [PubMed] [Google Scholar]
  310. Maddon P.J., Dalgleish A.G., McDougal J.S., Clapham P.R., Weiss R.A., Axel R. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell. 1986;47:333–348. doi: 10.1016/0092-8674(86)90590-8. [DOI] [PubMed] [Google Scholar]
  311. Manchester M., Liszewski M.K., Atkinson J.P., Oldstone M.B.A. Vol. 91. 1994. Multiple isoforms of CD46 (membrane cofactor protein) serve as receptors for measles virus; pp. 2161–2165. (Proc. Natl. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  312. Manson J., West J.D., Thomson V., McBride P.A., Kaufman M.H., Hope J. The prion protein gene: a role in mouse embryogenesis? Development. 1992;115:117–122. doi: 10.1242/dev.115.1.117. [DOI] [PubMed] [Google Scholar]
  313. Manuelidis E.E. Transmission of Creutzfeldt-Jakob disease from man to the guinea pig. Science. 1975;190:571–572. [PubMed] [Google Scholar]
  314. Manuelidis E.E., Manuelidis L. Vol. 90. 1993. A transmissible Creutzfeldt-Jakob disease-like agent is prevalent in the human population; pp. 7724–7728. (Proc. Natl. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  315. Manuelidis E.E., Angelo J.N., Gorgacz E.J., Manuelidis L. Transmission of Creutzfeldt-Jakob disease to Syrian hamster. Lancet. 1977;1:479. doi: 10.1016/s0140-6736(77)91959-6. [DOI] [PubMed] [Google Scholar]
  316. Manuelidis E.E., Gorgacz E.J., Manuelidis L. Transmission of Creutzfeldt-Jakob disease with scrapie-like syndromes to mice. Nature. 1978;271:778–779. doi: 10.1038/271778a0. [DOI] [PubMed] [Google Scholar]
  317. Manuelidis E.E., Gorgacz E.J., Manuelidis L. Vol. 75. 1978. Interspecies transmission of Creutzfeldt-Jakob disease to Syrian hamsters with reference to clinical syndromes and strains of agent; pp. 3432–3436. (Proc. Natl. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  318. Manuelidis L., Manuelidis E.E. Search for specific DNAs in Creutzfeldt-Jakob infectious brain fractions using “nick translation”. Virology. 1981;109:435–443. doi: 10.1016/0042-6822(81)90515-8. [DOI] [PubMed] [Google Scholar]
  319. Manuelidis L., Valley S., Manuelidis E.E. Vol. 82. 1985. Specific proteins associated with Creutzfeldt-Jakob disease and scrapie share antigenic and carbohydrate determinants; pp. 4263–4267. (Proc. Natl. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  320. Manuelidis L., Sklaviadis T., Manuelidis E.E. Evidence suggesting that PrP is not the infectious agent in Creutzfeldt-Jakob disease. EMBO J. 1987;6:341–347. doi: 10.1002/j.1460-2075.1987.tb04760.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  321. Maras B., Cardone F., Xi Y.G., Pocchiari M., Silvestrini M.C. Proteine 94, IX Convegno Nazionale. 1994. The mutated PrP (Val210Ile) is the only isoform which accumulates in the brain of a patient with familial Creutzfeldt-Jakob disease; p. 119. Verona abstract no. D43. [Google Scholar]
  322. Marsh R.F., Bessen R.A. Epidemiologic and experimental studies on transmissible mink encephalopathy. Dev. Biol. Stand. 1993;80:111–118. [PubMed] [Google Scholar]
  323. Marsh R.F., Bessen R.A., Lehmonn S., Hartsough G.R. Epidemiological and experimental studies on a new incident of trasmissible mink encephalopathy. J. Gen. Virol. 1991;72:589–594. doi: 10.1099/0022-1317-72-3-589. [DOI] [PubMed] [Google Scholar]
  324. Masters C.L., Gajdusek D.C. The spectrum of Creutzfeldt-Jakob disease and the virus-induced subacute spongiform encephalopathies. In: Smith W.T., Cavanagh J.B., editors. Recent Advances in Neuropathology. Churchill Livingstone; Edinburgh: 1982. pp. 139–163. [Google Scholar]
  325. Masters C.L., Richardson E.P.J. Subacute spongiform encephalopathy (Creutzfeldt-Jakob disease). The nature and progression of spongiform change. Brain. 1978;101:333–344. doi: 10.1093/brain/101.2.333. [DOI] [PubMed] [Google Scholar]
  326. Masters C.L., Harris J.O., Gajdusek D.C., Gibbs C.J., Jr, Bernoulli C., Asher D.M. Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann. Neurol. 1979;5:177–188. doi: 10.1002/ana.410050212. [DOI] [PubMed] [Google Scholar]
  327. Masters C.L., Gajdusek D.C., Gibbs C.J., Jr Creutzfeldt-Jakob disease virus isolations from the Gerstmann-Sträussler syndrome with an analysis of the various forms of amyloid plaque deposition in the virus-induced spongiform encephalopathies. Brain. 1981;104:559–588. doi: 10.1093/brain/104.3.559. [DOI] [PubMed] [Google Scholar]
  328. Masullo C., Pocchiari M., Neri G., Casaccia P., Iavarone A., Ladogana A., Macchi G. A retrospective study of Creutzfeldt-Jakob disease in Italy (1972–1986) Eur. J. Epidemiol. 1988;4:482–487. doi: 10.1007/BF00146403. [DOI] [PubMed] [Google Scholar]
  329. Masullo C., Pocchiari M., Macchi G., Alemà G., Piazza G., Panzera M.A. Transmission of Creutzfeldt-Jakob disease by dural cadaveric graft. J. Neurosurg. 1989;71:954–955. doi: 10.3171/jns.1989.71.6.0954. [DOI] [PubMed] [Google Scholar]
  330. Masullo C., Salvatore M., Macchi G., Genuardi M., Pocchiari M. Progressive dementia in a young patient with a homozygous deletion of the PrP gene. Ann. N. Y. Acad. Sci. 1994;724:358–360. doi: 10.1111/j.1749-6632.1994.tb38931.x. [DOI] [PubMed] [Google Scholar]
  331. Matthews W.B. Epidemiology of Creutzfeldt-Jakob disease in England and Wales. J. Neurol. Neurosurg. Psychiatry. 1975;38:210–213. doi: 10.1136/jnnp.38.3.210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  332. Mayer V., Orolin D., Mitrova E. Cluster of Creutzfeldt-Jakob disease and presenile dementia. Lancet. 1977;2:256. doi: 10.1016/s0140-6736(77)92881-1. [DOI] [PubMed] [Google Scholar]
  333. McBride P.A., Eikelenboom P., Kraal G., Fraser H., Bruce M.E. PrP protein is associated with follicular dendritic cells of spleens and lymph nodes in uninfected and scrapie-infected mice. J. Pathol. 1992;168:413–418. doi: 10.1002/path.1711680412. [DOI] [PubMed] [Google Scholar]
  334. McKinley M.P., Bolton D.C., Prusiner S.B. A protease-resistant protein is a structural component of the scrapie prion. Cell. 1983;35:57–62. doi: 10.1016/0092-8674(83)90207-6. [DOI] [PubMed] [Google Scholar]
  335. McKinley M.P., Masiarz F.R., Isaacs S.T., Hearst J.E., Prusiner S.B. Resistance of the scrapie agent to inactivation by psoralens. Photochem. Photobiol. 1983;37:539–545. doi: 10.1111/j.1751-1097.1983.tb04515.x. [DOI] [PubMed] [Google Scholar]
  336. McKinley M.P., Braunfeld M.B., Bellinger C.G., Prusiner S.B. Molecular characteristics of prion rods purified from scrapie-infected hamster brains. J. Infect. Dis. 1986;154:110–120. doi: 10.1093/infdis/154.1.110. [DOI] [PubMed] [Google Scholar]
  337. McKinley M.P., Hay B., Lingappa V.R., Lieberburg I., Prusiner S.B. Developmental expression of prion protein gene in brain. Dev. Biol. 1987;121:105–110. doi: 10.1016/0012-1606(87)90143-6. [DOI] [PubMed] [Google Scholar]
  338. McKinley M.P., Meyer R.K., Kenaga L., Rahbar F., Cotter R., Serban A., Prusiner S.B. Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis. J. Virol. 1991;65:1340–1351. doi: 10.1128/jvi.65.3.1340-1351.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  339. McKinley M.P., Taraboulos A., Kenaga L., Serban D., Stieber A., DeArmond S.J., Prusiner S.B., Gonatas N. Ultrastructural localization of scrapie prion proteins in cytoplasmic vesicles of infected cultured cells. Lab. Invest. 1991;65:622–630. [PubMed] [Google Scholar]
  340. Medori R., Tritschler H.J. Prion protein gene analysis in three kindreds with fatal familial insomnia (FFI): codon 178 mutation and codon 129 polymorphism. Am. J. Hum. Genet. 1993;53:822–827. [PMC free article] [PubMed] [Google Scholar]
  341. Medori R., Tritschler H.S., LeBlanc A.C., Villare F., Manetto V., Chen H.Y., Xue R., Leal S., Montagna P., Cortelli P., Tinuper P., Avoni P., Mochi M., Baruzzi A., Hauw J.J., Ott J., Lugaresi E., Autilio-Gambetti L., Gambetti P. Fatal Familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene. N. Engl. J. Med. 1992;326:444–449. doi: 10.1056/NEJM199202133260704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  342. Medori R., Montagna P., Tritschler H.J., LeBlanc A.C., Cortelli P., Tinuper P., Lugaresi E., Gambetti P. Fatal familial insomnia: a second kindred with mutation of prion protein gene at codon 178. Neurology. 1992;42:669–670. doi: 10.1212/wnl.42.3.669. [DOI] [PubMed] [Google Scholar]
  343. Mendelsohn C., Wimmer E., Racaniello V.R. Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell. 1989;56:855–865. doi: 10.1016/0092-8674(89)90690-9. [DOI] [PubMed] [Google Scholar]
  344. Merz P.A., Somerville R.A., Wisniewski H.M., Iqbal K. Abnormal fibrils from scrapie-infected brain. Acta Neuropathol. (Berl.) 1981;54:63–74. doi: 10.1007/BF00691333. [DOI] [PubMed] [Google Scholar]
  345. Merz P.A., Somerville R.A., Wisniewski H.M., Manuelidis L., Manuelidis E.E. Scrapie-associated fibrils in Creutzfeldt-Jakob disease. Nature. 1983;306:474–476. doi: 10.1038/306474a0. [DOI] [PubMed] [Google Scholar]
  346. Merz P.A., Wisniewski H.M., Somerville R.A., Bobin S.A., Masters C.L., Iqbal K. Ultrastructural morphology of amyloid fibrils from neuritic and amyloid plaques. Acta Neuropathol. (Berl.) 1983;60:113–124. doi: 10.1007/BF00685355. [DOI] [PubMed] [Google Scholar]
  347. Merz P.A., Rohwer R.G., Kascsak R.J., Wisniewski H.M., Somerville R.A., Gibbs C.J., Jr, Gajdusek D.C. Infection-specific particle from the unconventional slow virus diseases. Science. 1984;225:437–440. doi: 10.1126/science.6377496. [DOI] [PubMed] [Google Scholar]
  348. Meyer R.K., McKinley M.P., Bowman K.A., Braunfeld M.B., Barry R.A., Prusiner S.B. Vol. 83. 1986. Separation and properties of cellular and scrapie prion proteins; pp. 2310–2314. (Proc. Natl. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  349. Meyer N., Rosenbaum V., Schmidt B., Gilles K., Mirenda C.A., Groth D., Prusiner S.B., Riesner D. Search for a putative scrapie genome in purified prion fractions reveals a paucity of nucleic acids. J. Gen. Virol. 1991;72:37–49. doi: 10.1099/0022-1317-72-1-37. [DOI] [PubMed] [Google Scholar]
  350. Miller D.C. Creutzfeldt-Jakob disease in histopathology technicians. N. Engl. J. Med. 1988;318:853. doi: 10.1056/NEJM198803313181312. [DOI] [PubMed] [Google Scholar]
  351. Mitrova E., Mayer V. Inherited susceptibility, ovine brain consumption and Creutzfeldt-Jakob disease (CJD) J. Neurol. 1981;226:219–220. doi: 10.1007/BF00313385. [DOI] [PubMed] [Google Scholar]
  352. Miyashita K., Inuzuka T., Kondo H., Saito Y., Fujita N., Matsubara N., Tanaka R., Hinokuma K., Ikuta F., Miyatake T. Creutzfeldt-Jakob disease in a patient with a cadaveric dural graft. Neurology. 1991;41:940–941. doi: 10.1212/wnl.41.6.940. [DOI] [PubMed] [Google Scholar]
  353. Mizutani T., Okumura A., Oda M., Shiraki H. Panencephalopathic type of Creutzfeldt-Jakob disease: primary involvement of the cerebral white matter. J. Neurol. Neurosurg. Psychiatry. 1981;44:103–115. doi: 10.1136/jnnp.44.2.103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  354. Mobley W.C., Neve R.L., Prusiner S.B., McKinley M.P. Vol. 85. 1988. Nerve growth factor increases mRNA levels for the prion protein and the beta-amyloid protein precursor in developing hamster brain; pp. 9811–9815. (Proc. Natl. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  355. Moreau Dubois M.C., Brown P., Rohwer R.G., Masters C.L., Franko M., Gajdusek D.C. Experimental scrapie in golden Syrian hamsters: temporal comparison of in vitro cell-fusing activity with brain infectivity and histopathological changes. Infect. Immun. 1982;37:195–199. doi: 10.1128/iai.37.1.195-199.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  356. Mori S., Hamada C., Kumanishi T., Fukuhara N., Ichihashi Y., Ikuta F., Miyatake T., Tsubaki T. A Creutzfeldt-Jakob disease agent (Echigo-1 strain) recovered from brain tissue showing the ‘panencephalopathic type’ disease. Neurology. 1989;39:1337–1342. doi: 10.1212/wnl.39.10.1337. [DOI] [PubMed] [Google Scholar]
  357. Morrison M.E., Racaniello V.R. Molecular cloning and expression of a murine homolog of the human poliovirus receptor gene. J. Virol. 1992;66:2807–2813. doi: 10.1128/jvi.66.5.2807-2813.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  358. Morrison M.E., He Y.J., Wien M.W., Hogle J.M., Racaniello V.R. Homolog-scanning mutagenesis reveals poliovirus receptor residues important for virus binding and replication. J. Virol. 1994;68:2578–2588. doi: 10.1128/jvi.68.4.2578-2588.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  359. Muller W.E.G., Pfeifer K., Forrest J., Rytik P.G., Eremin V.F., Popov S.A., Schroder H.C. Accumulation of transcripts coding for prion protein in human astrocytes during infection with human immunodeficiency virus. Biochim. Biophys. Acta. 1992;1139:32–40. doi: 10.1016/0925-4439(92)90079-3. [DOI] [PubMed] [Google Scholar]
  360. Multhaup G., Diringer H., Hilmert H., Prinz H., Heukeshoven J., Beyreuther K. The protein component of scrapie-associated fibrils is a glycosylated low molecular weight protein. EMBO J. 1985;4:1495–1501. doi: 10.1002/j.1460-2075.1985.tb03808.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  361. Muramoto T., Kitamoto T., Zahirul Hoque M., Tateishi J., Goto I. Species barrier prevents an abnormal isoform of prion protein from accumulating in follicular dendritic cells of mice with Creutzfeldt-Jakob disease. J. Virol. 1993;67:6808–6810. doi: 10.1128/jvi.67.11.6808-6810.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  362. Murdoch G.H., Skalaviadis T., Manuelidis E.E., Manuelidis L. Potential retroviral RNAs in Creutzfeldt-Jakob disease. J. Virol. 1990;64:1477–1486. doi: 10.1128/jvi.64.4.1477-1486.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  363. Naniche D., Varior-Krishnan G., Cervoni F., Wild T.F., Rossi B., Rabourdin-Combe C., Gerlier D. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J. Virol. 1993;67:6025–6032. doi: 10.1128/jvi.67.10.6025-6032.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  364. Narang H.K. An electron microscopic study of natural scrapie sheep brain: further observations on virus-like particles and paramyxovirus-like tubules. Acta Neuropathol. (Berl.) 1974;28:317–329. doi: 10.1007/BF00685286. [DOI] [PubMed] [Google Scholar]
  365. Narang H.K. Detection of single-stranded DNA in scrapie-infected brain by electron microscopy. J. Mol. Biol. 1990;216:469–473. doi: 10.1016/0022-2836(90)90369-W. [DOI] [PubMed] [Google Scholar]
  366. Neary K., Caughey B., Ernst D., Race R.E., Chesebro B. Protease sensitivity and nuclease resistance of the scrapie agent propagated in vitro in neuroblastoma cells. J. Virol. 1991;65:1031–1034. doi: 10.1128/jvi.65.2.1031-1034.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  367. Neri G., FigàTalamanca L., Di Battista G.C., Lo Russo F. La amantadina nella malattia di Creutzfeldt-Jakob. Revisione della letteratura e contributo casistico. Riv. Neurobiol. 1984;30:47–56. [PubMed] [Google Scholar]
  368. Nevin S., McMenemey W.H., Behrman S., Jones D.P. Subacute spongiform encephalopathy — a subacute form of encephalopathy attributable to vascular dysfunction (spongiform cerebral atrophy) Brain. 1960;83:519–563. doi: 10.1093/brain/83.4.519. [DOI] [PubMed] [Google Scholar]
  369. Nieto A., Goldfarb L.G., Brown P., McCombie W.R., Trapp S., Asher D.M., Gajdusek D.C. Codon 178 mutation in ethnically diverse Creutzfeldt-Jakob disease families. Lancet. 1991;337:622–623. doi: 10.1016/0140-6736(91)91696-r. [DOI] [PubMed] [Google Scholar]
  370. Nochlin D., Sumi S.M., Bird T.D., Snow A.D., Leventhal C.M., Beyreuther K., Masters C.L. Familial dementia with PrP-positive amyloid plaques: a variant of Gerstmann-Sträussler syndrome. Neurology. 1989;39:910–918. doi: 10.1212/wnl.39.7.910. [DOI] [PubMed] [Google Scholar]
  371. Numerow G.R., Wolfert R., McNaughton M.E., Cooper N.R. Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2) J. Virol. 1985;55:347–351. doi: 10.1128/jvi.55.2.347-351.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  372. Oesch B., Westaway D., Walchli M., McKinley M.P., Kent S.B., Aebersold R., Barry R.A., Tempst P., Teplow D.B., Hood L.E., Prusiner S.B., Weissmann C. A cellular gene encodes scrapie PrP 27–30 protein. Cell. 1985;40:735–746. doi: 10.1016/0092-8674(85)90333-2. [DOI] [PubMed] [Google Scholar]
  373. Oesch B., Groth D.F., Prusiner S.B., Weissmann C. Vol. 135. 1988. Search for a scrapie-specific nucleic acid: a progress report; pp. 209–223. (Ciba Found. Symp.). [DOI] [PubMed] [Google Scholar]
  374. Oesch B., Westaway D., Prusiner S.B. Prion protein genes: evolutionary and functional aspects. Curr. Top. Microbiol. Immunol. 1991;172:109–124. doi: 10.1007/978-3-642-76540-7_7. [DOI] [PubMed] [Google Scholar]
  375. Owen F., Poulter M., Lofthouse R., Collinge J., Crow T.J., Risby D., Baker H.F., Ridley R.M., Hsiao K., Prusiner S.B. Insertion in prion protein gene in familial Creutzfeldt-Jakob disease. Lancet. 1989;1:51–52. doi: 10.1016/s0140-6736(89)91713-3. [DOI] [PubMed] [Google Scholar]
  376. Owen F., Poulter M., Collinge J., Crow T.J. A codon 129 polymorphism in the PRIP gene. Nucleic Acids Res. 1990;18:3103. doi: 10.1093/nar/18.10.3103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  377. Owen F., Poulter M., Collinge J., Crow T.J. Codon 129 changes in the prion protein gene in Caucasians. Am. J. Hum. Genet. 1990;46:1215–1216. [PMC free article] [PubMed] [Google Scholar]
  378. Özel M., Diringer H. An extraordinaly small, suspicious, virus-like structure in fractions from scrapie hamster brain. Lancet. 1994;343:894–895. doi: 10.1016/s0140-6736(94)90010-8. [DOI] [PubMed] [Google Scholar]
  379. Palmer A.C. Scrapie, a review of the literature. Vet. Rev. Annot. 1959;5:1–15. [Google Scholar]
  380. Palmer M.S., Collinge J. Mutations and polymorphisms in the prion protein gene. Hum. Mut. 1993;2:168–173. doi: 10.1002/humu.1380020303. [DOI] [PubMed] [Google Scholar]
  381. Palmer M.S., Dryden A.J., Hughes J.T., Collinge J. Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature. 1991;352:340–342. doi: 10.1038/352340a0. [DOI] [PubMed] [Google Scholar]
  382. Pan K.M., Baldwin M., Nguyen J., Gasset M., Serban A., Groth D., Mehlhorn I., Huang Z., Fletterick R.J., Cohen F.E., Prusiner S.B. Vol. 90. 1993. Conversion of α-helices into β-sheets features in the formation of the scrapie prion proteins; pp. 10962–10966. (Proc. Natl. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  383. Parry H.B. Academic Press; London: 1983. Scrapie Disease in Sheep. [Google Scholar]
  384. Pattison I.H. The relative susceptibility of sheep, goats and mice to two types of the goat scrapie agent. Res. Vet. Sci. 1966;7:207–212. [PubMed] [Google Scholar]
  385. Pattison I.H., Millson G.C. Experimental transmission of scrapie to goats and sheep by the oral route. J. Comp. Pathol. 1961;71:171–176. [Google Scholar]
  386. Pattison I.H., Millson G.C. Scrapie produced experimentally in goats with special reference to the clinical syndrome. J. Comp. Pathol. 1961;71:101–108. doi: 10.1016/s0368-1742(61)80013-1. [DOI] [PubMed] [Google Scholar]
  387. Pattison I.H., Hoare M.N., Jebbett J.N., Watson W.A. Spread of scrapie to sheep and goats by oral dosing with foetal membranes from scrapie-affected sheep. Vet. Rec. 1972;90:465–468. doi: 10.1136/vr.90.17.465. [DOI] [PubMed] [Google Scholar]
  388. Pattison I.H., Hoare M.N., Jebbett J.N., Watson W.A. Further observations on the production of scrapie in sheep by oral dosing with foetal membranes from scrapie-affected sheep. Br. Vet. J. 1974;130:Ixv–Ixvii. doi: 10.1016/s0007-1935(17)35851-7. [DOI] [PubMed] [Google Scholar]
  389. Peet R.L., Curran J.M. Spongiform encephalopathy in an importerd cheetah (Acinonyx jubatus) Aust. Vet. J. 1992;69:171. doi: 10.1111/j.1751-0813.1992.tb07506.x. [DOI] [PubMed] [Google Scholar]
  390. Petersen R.B., Tabaton M., Berg L., Schrank B., Torak R.M., Leal S., Julien J., Vital C., Deleplanque B., Pendlebury W.W., Drachman D., Smith T.W., Martin J.J., Oda M., Montagna P., Ott J., Autilio-Gambetti L., Lugaresi E., Gambetti P. Analysis of the prion protein gene in thalamic dementia. Neurology. 1992;42:1859–1863. doi: 10.1212/wnl.42.10.1859. [DOI] [PMC free article] [PubMed] [Google Scholar]
  391. Pocchiari M. Methodological aspects of the validation of purification procedures of human/animal derived products to remove unconventional slow viruses. Dev. Biol. Stand. 1991;75:87–95. [PubMed] [Google Scholar]
  392. Pocchiari M., D'Alessandro M. Registro nazionale della malattia di Creutzfeldt-Jakob. Resoconto di attivitä gennaio-dicembre 1993. Notiziario dell' Istituto Superiore di Sanitä. 1993;6:1–4. Suppl. [Google Scholar]
  393. Pocchiari M., Masullo C. Patogenesi dello scrapie: curve di crescita del ceppo 263K. In: Gainotti G., Bentivoglio M., Bergonzi P., Ferro F.M., editors. Neurologia e Scienze di Base. Vita e Pensiero; Milano: 1988. pp. 571–582. [Google Scholar]
  394. Pocchiari M., Schmittinger S., Masullo C. Amphotericin B delays the incubation period of scrapie in intracerebrally inoculated hamsters. J. Gen. Virol. 1987;68:219–223. doi: 10.1099/0022-1317-68-1-219. [DOI] [PubMed] [Google Scholar]
  395. Pocchiari M., Macchi G., Peano S., Conz A. Can potential hazard of Creutzfeldt-Jakob disease infectivity be reduced in the production of human growth hormone? Inactivation experiments with the 263K strain of scrapie. Arch. Virol. 1988;98:131–135. doi: 10.1007/BF01321014. [DOI] [PubMed] [Google Scholar]
  396. Pocchiari M., Casaccia P., Ladogana A. Amphotericin B: a novel class of antiscrapie drug. J. Infect. Dis. 1989;160:795–802. doi: 10.1093/infdis/160.5.795. [DOI] [PubMed] [Google Scholar]
  397. Pocchiari M., Peano S., Conz A., Eshkol A., Maillard F., Brown P., Gibbs C.J., Jr, Xi Y.G., Tenham Fisher E., Macchi G. Combination ultrafiltration and 6 M urea treatment of human growth hormone effectively minimizes risk from potential Creutzfeldt-Jakob disease virus contamination. Horm. Res. 1991;35:161–166. doi: 10.1159/000181894. [DOI] [PubMed] [Google Scholar]
  398. Pocchiari M., Salvatore M., Ladogana A., Ingrosso L., Xi Y.G., Cibati M., Masullo C. Experimental drug treatment of scrapie: a pathogenetic basis for rationale therapeutics. Eur. J. Epidemiol. 1991;7:556–561. doi: 10.1007/BF00143139. [DOI] [PubMed] [Google Scholar]
  399. Pocchiari M., Masullo C., Salvatore M., Genuardi M., Galgani S. Creutzfeldt-Jakob disease after non-commercial dura mater graft. Lancet. 1992;340:614–615. doi: 10.1016/0140-6736(92)92153-7. [DOI] [PubMed] [Google Scholar]
  400. Pocchiari M., Salvatore M., Cutruzzolä F., Genuardi M., Travaglini Allocatelli C., Masullo C., Macchi G., Alemä G., Galgani S., Xi Y.G., Petraroli R., Silvestrini M.C., Brunori M. A new point mutation of the prion protein gene in Creutzfeldt-Jakob disease. Ann. Neurol. 1993;34:802–807. doi: 10.1002/ana.410340608. [DOI] [PubMed] [Google Scholar]
  401. Poidinger M., Kirkwood J., Almond W. Sequence analysis of the PrP protein from two species of antelope susceptible to transmissible spongiform encephalopathy. Arch. Virol. 1993;131:193–199. doi: 10.1007/BF01379091. [DOI] [PubMed] [Google Scholar]
  402. Poulter M., Baker H.F., Frith C.D., Leach M., Lofthouse R., Ridley R.M., Shah T., Owen F., Collinge J., Brown J., Hardy J., Mullan M.J., Harding A.E., Bennet C., Doshi R., Crow T.J. Inherited prion disease with 144 base pair gene insertion. 1. Genealogical and molecular studies. Brain. 1992;115:675–685. doi: 10.1093/brain/115.3.675. [DOI] [PubMed] [Google Scholar]
  403. Powell Jackson J.D., Weller R.O., Kennedy P., Preece M.A., Whitcombe E.M., Newsom Davis J. Creutzfeldt-Jakob disease after administration of human growth hormone. Lancet. 1985;2:244–246. doi: 10.1016/s0140-6736(85)90292-2. [DOI] [PubMed] [Google Scholar]
  404. Prichard J.W., Thadani V., Kalb R., Manuelidis E.E. Rapidly progressive dementia in a patient who received a cadaveric dura mater graft. Morb. Mortal. Wkly Rep. 1987;36:49–55. [PubMed] [Google Scholar]
  405. Prusiner S.B. Novel proteinaceous infectious particles cause scrapie. Science. 1982;216:136–144. doi: 10.1126/science.6801762. [DOI] [PubMed] [Google Scholar]
  406. Prusiner S.B. Prions and neurodegenerative diseases. N. Engl. J. Med. 1987;317:1571–1581. doi: 10.1056/NEJM198712173172505. [DOI] [PubMed] [Google Scholar]
  407. Prusiner S.B. Natural and experimental prion disease of humans and animals. Curr. Op. Neurobiol. 1992;2:638–647. doi: 10.1016/0959-4388(92)90032-g. [DOI] [PubMed] [Google Scholar]
  408. Prusiner S.B. Genetic and infectious prion diseases. Arch. Neurol. 1993;50:1129–1153. doi: 10.1001/archneur.1993.00540110011002. [DOI] [PubMed] [Google Scholar]
  409. Prusiner S.B., Bolton D.C., Groth D.F., Bowman K.A., Cochran S.P., McKinley M.P. Further purification and characterization of scrapie prions. Biochemistry. 1982;21:6942–6950. doi: 10.1021/bi00269a050. [DOI] [PubMed] [Google Scholar]
  410. Prusiner S.B., Gajdusek D.C., Alpers M.P. Kuru with incubation periods exceeding two decades. Ann. Neurol. 1982;12:1–9. doi: 10.1002/ana.410120102. [DOI] [PubMed] [Google Scholar]
  411. Prusiner S.B., McKinley M.P., Bowman K.A., Bolton D.C., Bendheim P.E., Groth D.F., Glenner G.G. Scrapie prions aggregate to form amyloid-like birefringent rods. Cell. 1983;35:349–358. doi: 10.1016/0092-8674(83)90168-x. [DOI] [PubMed] [Google Scholar]
  412. Prusiner S.B., Groth D.F., Bolton D.C., Kent S.B., Hood L.E. Purification and structural studies of a major scrapie prion protein. Cell. 1984;38:127–134. doi: 10.1016/0092-8674(84)90533-6. [DOI] [PubMed] [Google Scholar]
  413. Prusiner S.B., Cochran S.P., Alpers M.P. Transmission of scrapie in hamsters. J. Infect. Dis. 1985;152:971–978. doi: 10.1093/infdis/152.5.971. [DOI] [PubMed] [Google Scholar]
  414. Prusiner S.B., Scott M., Foster D., Pan K.M., Groth D., Mirenda C.A., Torchia M., Yang S.L., Serban D., Carlson G.A., Hoppe P.C., Westaway D., DeArmond S.J. Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell. 1990;63:673–686. doi: 10.1016/0092-8674(90)90134-z. [DOI] [PubMed] [Google Scholar]
  415. Puckett C., Concannon P., Casey C., Hood L. Genomic structure of the human prion protein gene. Am. J. Hum. Genet. 1991;49:320–329. [PMC free article] [PubMed] [Google Scholar]
  416. Ratcliffe J., Rittman A., Wolf S., Verity M.A. Creutzfeldt-Jakob disease with focal onset unsuccessfully treated with amantadine. Bull. Los Angeles Neurol. Soc. 1975;40:18–20. [PubMed] [Google Scholar]
  417. Ren R., Racaniello V.R. Human poliovirus receptor gene expression and poliovirus tissue tropism in transgenic mice. J. Virol. 1992;66:296–304. doi: 10.1128/jvi.66.1.296-304.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  418. Ren R., Costantini F., Gorgacz E.J., Lee J.J., Racaniello V.R. Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis. Cell. 1990;63:353–362. doi: 10.1016/0092-8674(90)90168-e. [DOI] [PubMed] [Google Scholar]
  419. Ridley R.M., Baker H.F. Prion protein: A different concept of replication. Trends Neurosci. 1993;16:425–426. doi: 10.1016/0166-2236(93)90066-u. [DOI] [PubMed] [Google Scholar]
  420. Ripoll L., Laplanche J.L., Salzmamm M., Jouvet A., Planques B., Dussaucy M., Chatelain J., Beaudry P., Launay J.M. A new poin mutation in the prion protein gene at codon 210 in Creutzfeldt-Jakob disease. Neurology. 1993;43:1934–1938. doi: 10.1212/wnl.43.10.1934. [DOI] [PubMed] [Google Scholar]
  421. Robakis N.K., Devine Gage E.A., Jenkins E.C., Kascsak R.J., Brown W.T., Krawczun M.S., Silverman W.P. Localization of a human gene homologous to the PrP gene on the p arm of chromosome 20 and detection of PrP-related antigens in normal human brain. Biochem. Biophys. Res. Commun. 1986;140:758–765. doi: 10.1016/0006-291x(86)90796-5. [DOI] [PubMed] [Google Scholar]
  422. Robakis N.K., Sawh P.R., Wolfe G.C., Rubenstein R., Carp R.I., Innis M.A. Vol. 83. 1986. Isolation of a cDNA clone encoding the leader peptide of prion protein and expression of the homologous gene in various tissues; pp. 6377–6381. (Proc. Natl. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  423. Rogers M., Taraboulos A., Scott M., Groth D., Prusiner S.B. Intracellular accumulation of the cellular prion protein after mutagenesis of its Asn-linked glycosylation sites. Glycobiology. 1990;1:101–109. doi: 10.1093/glycob/1.1.101. [DOI] [PubMed] [Google Scholar]
  424. Rogers M., Yehiely F., Scott M., Prusiner S.B. Vol. 90. 1993. Conversion of truncated and elongated prion proteins into the scrapie isoform in cultured cells; pp. 3182–3186. (Proc. Natl. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  425. Rohwer R.G. The scrapie agent: “a virus by any other name”. Curr. Top. Microbiol. Immunol. 1991;172:195–232. [PubMed] [Google Scholar]
  426. Safar J., Wang W., Padgett M.P., Ceroni M., Piccardo P., Zopf D., Gajdusek D.C., Gibbs C.J., Jr . Vol. 87. 1990. Molecular mass, biochemical composition, and physicochemical behavior of the infectious form of the scrapie precursor protein monomer; pp. 6373–6377. (Proc. Natl. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  427. Safar J., Ceroni M., Gajdusek D.C., Gibbs C.J., Jr Differences in the membrane interaction of scrapie amyloid precursor proteins in normal and scrapie- or Creutzfeldt-Jakob disease-infected brains. J. Infect. Dis. 1991;163:488–494. doi: 10.1093/infdis/163.3.488. [DOI] [PubMed] [Google Scholar]
  428. Safar J., Roller P.P., Gajdusek D.C., Gibbs C.J., Jr Conformational transitions, dissociation, and unfolding of scrapie amyloid (prion) protein. J. Biol. Chem. 1993;268:20276–20284. [PubMed] [Google Scholar]
  429. Salvatore M., Genuardi M., Petraroli R., Masullo C., D'Alessandro M., Pocchiari M. Polymorphisms of the prion protein gene in Italian patients with Creutzfeldt-Jakob disease. Hum. Genet. 1994 doi: 10.1007/BF00201596. in press. [DOI] [PubMed] [Google Scholar]
  430. Sanders W.L. Creutzfeldt-Jakob disease treated with amantadine. J. Neurol. Neurosurg. Psychiatry. 1979;42:960–961. doi: 10.1136/jnnp.42.10.960. [DOI] [PMC free article] [PubMed] [Google Scholar]
  431. Sanders W.L., Dunn T.L. Creutzfeldt-Jakob disease treated with amantadine. A report of two cases. J. Neurol. Neurosurg. Psychiatry. 1973;36:581–584. doi: 10.1136/jnnp.36.4.581. [DOI] [PMC free article] [PubMed] [Google Scholar]
  432. Sawcer S.J., Yuill G.M., Esmonde T.F., Estibeiro P., Ironside J.W., Bell J.E., Will R.G. Creutzfeldt-Jakob disease in an individual occupationally exposed to BSE. Lancet. 1993;341:642. doi: 10.1016/0140-6736(93)90414-c. [DOI] [PubMed] [Google Scholar]
  433. Scott J.R., Davies D., Fraser H. Scrapie in the central nervous sistem: neuroanatomical spread of infection and Sinc control of pathogenesis. J. Gen. Virol. 1992;73:1637–1644. doi: 10.1099/0022-1317-73-7-1637. [DOI] [PubMed] [Google Scholar]
  434. Scott M., Foster D., Mirenda C.A., Serban D., Coufal F., Walchli M., Torchia M., Groth D., Carlson G., DeArmond S.J., Westaway D., Prusiner S.B. Transgenic mice expressing hamster prion protein pruduce species-specific scrapic infectivity and amyloid plaques. Cell. 1989;59:847–857. doi: 10.1016/0092-8674(89)90608-9. [DOI] [PubMed] [Google Scholar]
  435. Scott M., Groth D., Foster D., Torchia M., Yang S.L., DeArmond S.J., Prusiner S.B. Propagation of prions with artificial properties in transgenic mice expressing chimeric PrP genes. Cell. 1993;73:979–988. doi: 10.1016/0092-8674(93)90275-u. [DOI] [PubMed] [Google Scholar]
  436. Scully R.E., Galdabini J.J., McNelly B.U. Case records of the Massachusetts General Hospital. N. Engl. J. Med. 1980;303:1162–1171. doi: 10.1056/NEJM198011133032008. [DOI] [PubMed] [Google Scholar]
  437. Shyng S.L., Huber M.T., Harris D.A. A prion protein cycles between the cell surface and an endocytic compartment in cultured neuroblastoma cells. J. Biol. Chem. 1993;268:15922–15928. [PubMed] [Google Scholar]
  438. Sitwell L., Lach B., Atack E., Atack D., Izukawa D. Creutzfeldt-Jakob disease in histopathology technicians. N. Engl. J. Med. 1988;318:854. doi: 10.1056/NEJM198803313181312. [DOI] [PubMed] [Google Scholar]
  439. Sklaviadis T., Manuelidis L., Manuelidis E.E. Vol. 83. 1986. Characterization of major peptides in Creutzfeldt-Jakob disease and scrapic; pp. 6146–6150. (Proc. Natl. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  440. Sklaviadis T., Akowitz A., Manuelidis E.E., Manuelidis L. Nuclease treatment results in high specific purification of Creutzfeldt-Jakob disease infectivity with a density characteristic of nucleic acid-protein complexes. Arch. Virol. 1990;112:215–228. doi: 10.1007/BF01323166. [DOI] [PubMed] [Google Scholar]
  441. Sklaviadis T., Akowitz A., Manuelidis E.E., Manuelidis L. Vol. 90. 1993. Nucleic acid binding proteins in highly purified Creutzfeldt-Jakob disease preparations; pp. 5713–5717. (Proc. Natl. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  442. Somerville R.A., Ritchie L.A., Gibson P.H. Structural and biochemical evidence that scrapie-associated fibrils assemble in vivo. J. Gen. Virol. 1989;70:25–35. doi: 10.1099/0022-1317-70-1-25. [DOI] [PubMed] [Google Scholar]
  443. Sparkes R.S., Simon M., Cohn V.H., Fournier R.E., Lem J., Klisak I., Heinzmann C., Blatt C., Lucero M., Mohandas T., DeArmond S.J., Westaway D., Prusiner S.B., Weiner L.P. Vol. 83. 1986. Assignment of the human and mouse prion protein genes to homologous chromosomes; pp. 7358–7362. (Proc. Natl. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  444. Spielmeyer W. Springer; Berlin: 1922. Histopathologie des Nervensystems. [Google Scholar]
  445. Stahl N., Borchelt D.R., Hsiao K., Prusiner S.B. Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell. 1987;51:229–240. doi: 10.1016/0092-8674(87)90150-4. [DOI] [PubMed] [Google Scholar]
  446. Stahl N., Baldwin M.A., Burlingame A.L., Prusiner S.B. Identification of glycoinositol phospholipid linked and truncated forms of the scrapie prion protein. Biochemistry. 1990;29:8879–8884. doi: 10.1021/bi00490a001. [DOI] [PubMed] [Google Scholar]
  447. Stahl N., Borchelt D.R., Prusiner S.B. Differential release of cellular and scrapic prion proteins from cellular membranes by phosphatidylinositol-specific phospholipase. Biochemistry. 1990;29:5405–5412. doi: 10.1021/bi00474a028. [DOI] [PubMed] [Google Scholar]
  448. Stahl N., Baldwin M.A., Hecker R., Pan K.M., Burlingame A.L., Prusiner S.B. Glycosylinositol phospholipid anchors of the scrapic and cellular prion proteins contain sialic acid. Biochemistry. 1992;31:5043–5053. doi: 10.1021/bi00136a600. [DOI] [PubMed] [Google Scholar]
  449. Stahl N., Baldwin M.A., Teplow D.B., Hood L., Gibson B.W., Burlingame A.L., Prusiner S.B. Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. Biochemistry. 1993;32:1991–2002. doi: 10.1021/bi00059a016. [DOI] [PubMed] [Google Scholar]
  450. Staunton D.E., Merluzzi V.J., Rothlein R., Barton R., Marlin S.D., Springer T.A. A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses. Cell. 1989;56:849–853. doi: 10.1016/0092-8674(89)90689-2. [DOI] [PubMed] [Google Scholar]
  451. Stockman S. Contribution to the study of the disease known as scrapie. J. Comp. Path. Ther. 1926;39:42–71. [Google Scholar]
  452. Tagliavini F., Prelli F., Ghiso J., Bugiani O., Serban D., Prusiner S.B., Farlow M.R., Ghetti B., Frangione B. Amyloid protein of Gerstmann-Sträussler-Scheinker disease (Indiana kindred) is an 11 kd fragment of prion protein with an N-terminal glycine at codon 58. EMBO J. 1991;10:513–519. doi: 10.1002/j.1460-2075.1991.tb07977.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  453. Tagliavini F., Prelli F., Verga L., Giaccone G., Sarma R., Gorevic P., Ghetti B., Passerini F., Ghibaudi E., Forloni G., Salmona M., Bugiani O., Frangione B. Vol. 90. 1993. Synthetic peptides homologous to prion protein residues 106–147 form amyloid-like fibrils in vitro; pp. 9678–9682. (Proc. Natl. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  454. Taguchi F., Tamai Y., Uchida K., Kitajima R., Kojima H., Kawaguchi T., Ohtani Y., Miura S. Proposal for a procedure for complete inactivation of the Creutzfeldt-Jakob disease agent. Arch. Virol. 1991;119:297–301. doi: 10.1007/BF01310679. [DOI] [PubMed] [Google Scholar]
  455. Taraboulos A., Rogers M., Borchelt D.R., McKinley M.P., Scott M., Serban D., Prusiner S.B. Vol. 87. 1990. Acquisition of protease resistance by prion proteins in scrapie-infected cells does not require asparagine-linked glycosylation; pp. 8262–8266. (Proc. Natl. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  456. Taraboulos A., Raeber A.J., Borchelt D.R., Serban D., Prusiner S.B. Synthesis and trafficking of prion proteins in cultured cells. Mol. Biol. Cell. 1992;3:851–863. doi: 10.1091/mbc.3.8.851. [DOI] [PMC free article] [PubMed] [Google Scholar]
  457. Tateishi J. Antibiotics and antivirals do not modify experimentally-induced Creutzfeldt-Jakob disease in mice. J. Neurol. Neurosurg. Psychiat. 1981;44:723–724. doi: 10.1136/jnnp.44.8.723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  458. Tateishi J., Ohta M., Koga M., Sato Y., Kuroiwa Y. Transmission of chronic spongiform encephalopathy with kuru plaques from humans to small rodents. Ann. Neurol. 1979;5:581–584. doi: 10.1002/ana.410050616. [DOI] [PubMed] [Google Scholar]
  459. Tateishi J., Kitamoto T., Doh-ura K., Sakaki Y., Steinmetz G., Tranchant C., Warter J.M., Heldt N. Immunochemical, molecular genetic and transmission studies on a case of Gerstmann-Sträussler-Scheinker syndrome. Neurology. 1990;40:1578–1581. doi: 10.1212/wnl.40.10.1578. [DOI] [PubMed] [Google Scholar]
  460. Tateishi J., Doh-ura K., Kitamoto T., Tranchant C., Steinmetz G., Warter J.M., Boellaard J.W. Prion protein gene analysis and transmission studies of Creutzfeldt-Jakob disease. In: Prusiner S.B., Collinge J., Powell J., Anderton B., editors. Prion Diseases of Humans and Animals. Ellis Horwood; New York: 1992. pp. 129–138. [Google Scholar]
  461. Taylor D.M. Inactivation of SE agents. Br. Med. Bull. 1993;49:810–821. doi: 10.1093/oxfordjournals.bmb.a072648. [DOI] [PubMed] [Google Scholar]
  462. Terzano M.G., Montanari E., Calzetti S., Mancia D., Lechi A. The effect of amantadine on arousal and EEG patterns in Creutzfeldt-Jakob disease. Arch. Neurol. 1983;40:555–559. doi: 10.1001/archneur.1983.04050080055010. [DOI] [PubMed] [Google Scholar]
  463. Thadani V., Penar P.L., Partington J., Kalb R., Janssen R., Schonberger L.B., Rabkin C.S., Prichard J.W. Creutzfeldt-Jakob disease probably acquired from a cadaveric dura mater graft. Case report. J. Neurosurg. 1988;69:766–769. doi: 10.3171/jns.1988.69.5.0766. [DOI] [PubMed] [Google Scholar]
  464. Tischer I., Gelderblom H., Vemermann W., Koch M.A. A very small porcine virus with circular single-stranded DNA. Nature. 1982;295:64–66. doi: 10.1038/295064a0. [DOI] [PubMed] [Google Scholar]
  465. Tomassini J.E., Graham D., DeWitt C.M., Lineberger D.W., Rodkey J.A., Colonno R.J. Vol. 86. 1989. cDNA cloning reveals that the major group rhinovirus receptor on HeLa cells is intercellular adhesion molecule 1; pp. 4907–4911. (Proc. Natl. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  466. Tranchant C., Doh-ura K., Warter J.M., Steinmetz G., Chevalier Y., Hanauer A., Kitamoto T., Tateishi J. Gerstmann-Sträussler-Scheinker disease in an Alsatian family: clinical and genetic studies. J. Neurol. Neurosurg. Psychiat. 1992;55:185–187. doi: 10.1136/jnnp.55.3.185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  467. Tsuji S., Kuroiwa Y. Creutzfeldt-Jakob disease in Japan. Neurology. 1983;33:1503–1506. doi: 10.1212/wnl.33.11.1503. [DOI] [PubMed] [Google Scholar]
  468. Turk E., Teplow D.B., Hood L.E., Prusiner S.B. Purification and properties of the cellular and scrapie hamster prion proteins. Eur. J. Biochem. 1988;176:21–30. doi: 10.1111/j.1432-1033.1988.tb14246.x. [DOI] [PubMed] [Google Scholar]
  469. Vernon M.L., Horta Barbosa L., Fuccillo D.A., Sever J.L., Baringer J.R., Birnbaum G. Virus-like particles and nucleoprotein-type filaments in brain tissue from two patients with Creutzfeldt-Jakob disease. Lancet. 1970;1:964–966. doi: 10.1016/s0140-6736(70)91095-0. [DOI] [PubMed] [Google Scholar]
  470. Villa G., Caltagirone C., Macchi G. Unusual clinical course in a case of Creutzfeldt-Jakob disease. Ital. J. Neurol. Sci. 1982;3:155–158. doi: 10.1007/BF02043951. [DOI] [PubMed] [Google Scholar]
  471. Vnencak Jones C.L., Phillips J.A. Identification of heterogeneous PrP gene deletions in controls by detection of allele-specific heteroduplexes (DASH) Am. J. Hum. Genet. 1992;50:871–872. [PMC free article] [PubMed] [Google Scholar]
  472. Walker A.S., Inderlied C.B., Kingsbury D.T. Conditions for the chemical and physical inactivation of the K. Fu. strain of the agent of Creutzfeldt-Jakob disease. Am. J. Public Health. 1983;73:661–665. doi: 10.2105/ajph.73.6.661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  473. Weissmann C. A ‘unified theory’ of prion propagation. Nature. 1991;352:679–683. doi: 10.1038/352679a0. [DOI] [PubMed] [Google Scholar]
  474. Weissmann C. Molecular biology of prion diseases. Trends Cell Biol. 1994;4:10–14. doi: 10.1016/0962-8924(94)90032-9. [DOI] [PubMed] [Google Scholar]
  475. Wells G.A., Scott A.C., Johnson C.T., Gunning R.F., Hancock R.D., Jeffrey M., Dawson M., Bradley R. A novel progressive spongiform encephalopathy in cattle. Vet. Rec. 1987;121:419–420. doi: 10.1136/vr.121.18.419. [DOI] [PubMed] [Google Scholar]
  476. Westaway D., Prusiner S.B. Conservation of the cellular gene encoding the scrapie prion protein. Nucleic Acids Res. 1986;14:2035–2044. doi: 10.1093/nar/14.5.2035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  477. Westaway D., Goodman P.A., Mirenda C.A., McKinley M.P., Carlson G.A., Prusiner S.B. Distinct prion proteins in short and long scrapie incubation period mice. Cell. 1987;51:651–662. doi: 10.1016/0092-8674(87)90134-6. [DOI] [PubMed] [Google Scholar]
  478. Westaway D., DeArmond S.J., Cayetano-Canlas J., Groth D., Foster D., Yang S.-L., Torchia M., Carlson G.A., Prusiner S.B. Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins. Cell. 1994;76:117–129. doi: 10.1016/0092-8674(94)90177-5. [DOI] [PubMed] [Google Scholar]
  479. Wilesmith J.W., Wells G.A., Cranwell M.P., Ryan J.B. Bovine spongiform encephalopathy: epidemiological studies. Vet. Rec. 1988;123:638–644. [PubMed] [Google Scholar]
  480. Wilesmith J.W., Ryan J.B., Atkinson M.J. Bovine spongiform encephalopathy; epidemiological studies on the origin. Vet. Rec. 1991;128:199–203. doi: 10.1136/vr.128.9.199. [DOI] [PubMed] [Google Scholar]
  481. Wilesmith J.W., Hoinville L.J., Ryan J.B.M., Sayers A.R. Bovine spongiform encephalopathy: aspects of the clinical picture and analyses of possible changes 1986–1990. Vet. Rec. 1992;130:197–201. doi: 10.1136/vr.130.10.197. [DOI] [PubMed] [Google Scholar]
  482. Will R.G., Matthews W.B. Evidence for case-to-case transmission of Creutzfeldt-Jakob disease. J. Neurol. Neurosurg. Psychiat. 1982;45:235–238. doi: 10.1136/jnnp.45.3.235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  483. Will R.G., Matthews W.B. A retrospective study of Creutzfeldt-Jakob disease in England and Wales 1970–1979. I: Clinical features. J. Neurol. Neurosurg. Psychiat. 1984;47:134–140. doi: 10.1136/jnnp.47.2.134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  484. Will R.G., Ironside J.W., Bell J.E. Bovine spongiform encephalopathy and risk to health. Br. Med. J. 1992;305:53. doi: 10.1136/bmj.305.6844.53-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  485. Williams E.S., Young S. Chronic wasting disease of captive mule deer: a spongiform encephalopathy. J. Wild. Dis. 1980;16:89–98. doi: 10.7589/0090-3558-16.1.89. [DOI] [PubMed] [Google Scholar]
  486. Williams E.S., Young S. Spongiform encephalopathy of Rocky Mountain elk. J. Wild. Dis. 1982;18:465–471. doi: 10.7589/0090-3558-18.4.465. [DOI] [PubMed] [Google Scholar]
  487. Williams E.S., Young S., Marsh R.F. Preliminary evidence of transmissibility of chronic wasting disease of mule deer. Proceedings of the Wildlife Disease Association Annual Conference; 19 August 1982, Madison, Wisconsin; 1982. Abstract no.22. [Google Scholar]
  488. Willison H.J., Gale A.N., McLaughlin J.E. Creutzfeldt-Jakob disease following cadaveric dura mater graft. J. Neurol. Neurosurg. Psychiat. 1991;54:940. doi: 10.1136/jnnp.54.10.940. [DOI] [PMC free article] [PubMed] [Google Scholar]
  489. Willoughby K., Kelly D.F., Lyon D.G., Wells G.A.H. Spongiform encephalopathy in a captive puma (Panthera concolour, felis concolour) Vet. Rec. 1992;131:431–434. doi: 10.1136/vr.131.19.431. [DOI] [PubMed] [Google Scholar]
  490. Wilson D.R., Anderson R.D., Smith W. Studies in scrapie. J. Comp. Pathol. 1950;60:267–282. doi: 10.1016/s0368-1742(50)80025-5. [DOI] [PubMed] [Google Scholar]
  491. Wion D., Le Bert M., Brachet P. Messenger RNAs of beta-amyloid precursor protein and prion protein are regulated by nerve growth factor in PC12 cells. Int. J. Dev. Neurosci. 1988;6:387–393. doi: 10.1016/0736-5748(88)90021-4. [DOI] [PubMed] [Google Scholar]
  492. Wood J.L., Lund L.J., Done S.H. The natural occurrence of scrapie in moufflon. Vet. Rec. 1992;130:25–27. doi: 10.1136/vr.130.2.25. [DOI] [PubMed] [Google Scholar]
  493. Wu Y., Brown W.T., Robakis N.K., Dobkin C., Devine Gage E., Merz P.A., Wisniewski H.M. A PvuII RFLP detected in the human prion protein (PrP) gene. Nucleic Acids Res. 1987;15:3191. doi: 10.1093/nar/15.7.3191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  494. Wyatt J.M., Pearson G.R., Smerdon T., Gruffydd Jones T.J., Wells G.A.H. Spongiform encephalopathy in a cat. Vet. Rec. 1990;126:513. [Google Scholar]
  495. Wyatt J.M., Pearson G.R., Smerdon T.N., Gruffydd Jones T.J., Wells G.A., Wilesmith J.W. Naturally occurring scrapie-like spongiform encephalopathy in five domestic cats. Vet. Rec. 1991;129:233–236. doi: 10.1136/vr.129.11.233. [DOI] [PubMed] [Google Scholar]
  496. Xi Y.G., Ingrosso L., Ladogana A., Masullo C., Pocchiari M. Amphotericin B treatment dissociates in vivo replication of the scrapie agent from PrP accumulation. Nature. 1992;356:598–601. doi: 10.1038/356598a0. [DOI] [PubMed] [Google Scholar]
  497. Xi Y.G., Cardone F., Pocchiari M. Detection of proteinase-resistant protein (PrP) in small brain tissue samples from Creutzfeldt-Jakob disease patients. J. Neurol. Sci. 1994 doi: 10.1016/0022-510x(94)90323-9. in press. [DOI] [PubMed] [Google Scholar]
  498. Yamada M., Itoh Y., Fujigasaki H., Haruse S., Kaneko K., Kitamoto T., Tateishi J., Otomo E., Hayakawa M., Tanaka J., Matsushita M., Miyatake T. A missense mutation at codon 105 with codon 129 polymorphism of the prion protein gene in a new variant of Gerstmann-Sträussler-Scheinker disease. Neurology. 1993;43:2723–2724. doi: 10.1212/wnl.43.12.2723-a. [DOI] [PubMed] [Google Scholar]
  499. Yeager C.L., Ashmun A., Williams R.K., Cardellichio C.B., Shapiro L.H., Look A.T., Holmes K.V. Human aminopeptidase N is a receptor for human coronavirus 229E. Nature. 1992;357:420–422. doi: 10.1038/357420a0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  500. Young J.A.T., Bates P., Varmus H.E. Isolation of a chicken gene that confers susceptibility to infection by subgroup A avian leukosis and sarcoma viruses. J. Virol. 1993;67:1811–1816. doi: 10.1128/jvi.67.4.1811-1816.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  501. Zilber N., Kahana E., Abraham M. The Libyan Creutzfeldt-Jakob disease focus in Israel: an epidemiologic evaluation. Neurology. 1991;41:1385–1389. doi: 10.1212/wnl.41.9.1385. [DOI] [PubMed] [Google Scholar]
  502. Zlotnik I., Barlow R.M. The transmission of a specific encephaloapthy of mink to the goat. Vet. Rec. 1967;82:55–56. doi: 10.1136/vr.81.2.55. [DOI] [PubMed] [Google Scholar]
  503. Zlotnik I., Rennie J.C. The pathology of the brain of mice inoculated with tissues from scrapie sheep. J. Comp. Pathol. 1962;72:360–365. doi: 10.1016/s0368-1742(62)80041-1. [DOI] [PubMed] [Google Scholar]

Articles from Molecular Aspects of Medicine are provided here courtesy of Elsevier

RESOURCES